Advanced
  Home Compare Reports

Comparison with Similar Reports

Analytical Standards Market by Category (Organic, Inorganic), Technique (GC, MS, LC, IR, NMR, Gravimetry), Method (Bioanalytical, Dissolution, Materia...

by Category (Organic, Inorganic), Technique (GC, MS, LC, IR, NMR, Gravimetry), Method (Bioanalytical, Dissolution, Material Testing), Application (Food, Environmental, Pharmaceutical, Forensics)

Publisher:        MarketsandMarkets

# of Pages:        252

Rating: 

1 User License $4,950

Publication Date:  November, 2020

Price:       $4,950 / User License




TABLE OF CONTENTS

 

1              INTRODUCTION                34

1.1          OBJECTIVES OF THE STUDY          34

1.2          PRODUCT DEFINITION   34

1.3          MARKET SCOPE                35

1.3.1      MARKETS COVERED        35

1.3.2      YEARS CONSIDERED FOR THE STUDY        36

1.4          CURRENCY USED FOR THE STUDY              36

1.5          STAKEHOLDERS 36

1.6          SUMMARY OF CHANGES              37

2              RESEARCH METHODOLOGY         38

2.1          RESEARCH DATA               38

FIGURE 1             RESEARCH DESIGN          38

2.1.1      SECONDARY DATA           39

2.1.1.1   INDICATIVE LIST OF SECONDARY SOURCES           40

2.1.2      PRIMARY DATA 41

FIGURE 2             BREAKDOWN OF PRIMARIES: ANALYTICAL STANDARDS MARKET               41

2.2          MARKET ESTIMATION METHODOLOGY  41

FIGURE 3             RESEARCH METHODOLOGY: HYPOTHESIS BUILDING         42

2.2.1      END USER -BASED MARKET ESTIMATION              42

2.2.2      REVENUE MAPPING-BASED MARKET ESTIMATION           43

FIGURE 4             MARKET SIZE ESTIMATION: ANALYTICAL STANDARDS MARKET   43

2.2.3      PRIMARY RESEARCH VALIDATION            43

2.3          DATA TRIANGULATION 44

FIGURE 5             DATA TRIANGULATION METHODOLOGY               44

2.4          RESEARCH ASSUMPTIONS           45

2.5          RESEARCH LIMITATIONS               45

3              EXECUTIVE SUMMARY  46

FIGURE 6             ANALYTICAL STANDARDS MARKET, BY CATEGORY,

2020 VS. 2025 (USD BILLION        46

FIGURE 7             ANALYTICAL STANDARDS MARKET, BY TECHNIQUE,

2020 VS. 2025 (USD BILLION)       47

FIGURE 8             GLOBAL ANALYTICAL STANDARDS MARKET, BY PRODUCT,

2020 VS. 2025 (USD BILLION)       48

FIGURE 9             GLOBAL ANALYTICAL STANDARDS MARKET, BY METHODOLOGY,

2020 VS. 2025 (USD BILLION)       48

FIGURE 10           NORTH AMERICA TO COMMAND THE LARGEST SHARE OF THE GLOBAL ANALYTICAL STANDARDS MARKET                49

 

4              PREMIUM INSIGHTS       51

4.1          GLOBAL ANALYTICAL STANDARDS MARKET OVERVIEW  51

FIGURE 11           RISING PUBLIC-PRIVATE INVESTMENTS FOR RESEARCH ACTIVITIES AND

THE STRINGENT REGULATORY SCENARIO IN THE PHARMACEUTICAL INDUSTRY ARE KEY FACTORS DRIVING THE GROWTH OF THIS MARKET     51

4.2          ANALYTICAL STANDARDS MARKET, BY PRODUCT, 2020 VS. 2025 (USD MILLION) 52

FIGURE 12           ENVIRONMENTAL ANALYTICAL STANDARDS SEGMENT IS EXPECTED TO DOMINATE THE MARKET BY 2025                52

4.3          GEOGRAPHIC ANALYSIS: ANALYTICAL STANDARDS MARKET, BY CATEGORY          53

FIGURE 13           ASIA PACIFIC REGION IS ESTIMATED TO BE A HIGH GROWTH RATE MARKET         53

4.4          ASIA PACIFIC: ANALYTICAL STANDARDS MARKET, BY TECHNIQUE AND COUNTRY (2020)                53

FIGURE 14           CHROMATOGRAPHY SEGMENT IS EXPECTED TO DOMINATE THE ASIA PACIFIC MARKET  53

4.5          ANALYTICAL STANDARDS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES      54

FIGURE 15           ASIA PACIFIC TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD 54

5              MARKET OVERVIEW       55

5.1          INTRODUCTION                55

5.2          MARKET DYNAMICS       55

FIGURE 16           GLOBAL ANALYTICAL STANDARDS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES                55

5.2.1      KEY MARKET DRIVERS    56

5.2.1.1   RISING PUBLIC CONCERNS RELATED TO OPTIMAL FOOD SAFETY & QUALITY         56

5.2.1.2   GROWING APPLICATIONS OF ANALYTICAL TECHNIQUES IN PROTEOMICS AND METABOLOMICS                57

5.2.1.3   EXPANSION OF PHARMACEUTICAL & BIOTECHNOLOGY INDUSTRIES WORLDWIDE            57

FIGURE 17           R&D EXPENDITURE OF THE TOP 10 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, IN 2020 (USD BILLION)              58

5.2.1.4   INCREASING ADOPTION OF ANALYTICAL TECHNIQUES IN PESTICIDE MONITORING          58

5.2.1.5   STRINGENT REGULATORY SCENARIO IN THE PHARMACEUTICAL INDUSTRY           59

5.2.1.6   INCREASING R&D FOR PUBLIC-PRIVATE INVESTMENTS  59

5.2.1.7   GREATER REGULATORY EMPHASIS ON EFFECTIVE POLLUTION MONITORING & CONTROL              60

5.2.2      KEY MARKET RESTRAINTS             60

5.2.2.1   LIMITED PUBLIC AWARENESS RELATED TO EFFECTIVE POLLUTION MONITORING STRATEGIES      60

5.2.2.2   STRINGENT STORAGE REQUIREMENTS FOR THE SUCCESSFUL DEPLOYMENT OF ANALYTICAL STANDARDS              61

5.2.3      KEY MARKET OPPORTUNITIES    61

5.2.3.1   PATENT EXPIRY OF MAJOR DRUGS AND BIOMOLECULES               61

TABLE 1                DRUGS THAT LOST PATENT PROTECTION BETWEEN 2011 & 2017 61

TABLE 2                DRUGS EXPECTED TO LOSE PATENT PROTECTION BETWEEN 2017 & 2020                62

5.2.3.2   INCREASING NUMBER OF CLINICAL TRIALS WORLDWIDE               62

TABLE 3                NUMBER OF CLINICAL TRIALS ACROSS THE WORLD, AS OF 2020  63

5.2.4      KEY MARKET CHALLENGES           63

5.2.4.1   UNAVAILABILITY OF THE FULL SPECTRUM OF ANALYTICAL STANDARDS  63

5.2.4.2   SHORTAGE OF SKILLED LABORATORY TECHNICIANS         64

5.2.5      REGULATORY SCENARIO               64

5.2.6      PRICING ANALYSIS          66

TABLE 4                ANALYTICAL STANDARDS PRICING ANALYSIS, BY TECHNIQUE, 2019 (USD)             66

5.2.7      COVID-19 IMPACT           66

5.2.8      ECOSYSTEM COVERAGE                67

6              ANALYTICAL STANDARDS MARKET, BY TECHNIQUE          68

6.1          INTRODUCTION                69

TABLE 5                ANALYTICAL STANDARDS MARKET SIZE, BY TECHNIQUE,

2018–2025 (USD MILLION)           69

6.2          CHROMATOGRAPHY      69

TABLE 6                CHROMATOGRAPHY MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION) 70

TABLE 7                CHROMATOGRAPHY MARKET SIZE, BY REGION, 2018–2025 (USD MILLION)           70

TABLE 8                CHROMATOGRAPHY STANDARDS MARKET SIZE, BY CATEGORY,

2018–2025 (USD MILLION)           71

TABLE 9                CHROMATOGRAPHY MARKET SIZE, BY PRODUCT,

2018–2025 (USD MILLION)           71

TABLE 10              CHROMATOGRAPHY MARKET SIZE, BY METHODOLOGY,

2018–2025 (USD MILLION)           71

6.2.1      ION CHROMATOGRAPHY             72

6.2.1.1   MULTIPLE ION ANALYSIS IN A SINGLE RUN OF ION CHROMATOGRAPHY TO SUPPLEMENT THE MARKET GROWTH                72

TABLE 11              ION CHROMATOGRAPHY MARKET SIZE, BY REGION,

2018–2025 (USD MILLION)           72

6.2.2      GAS CHROMATOGRAPHY             72

6.2.2.1   THE HIGH STABILITY AND SENSITIVITY OF THIS TECHNIQUE DRIVES SEGMENT GROWTH  72

TABLE 12              GAS CHROMATOGRAPHY MARKET SIZE, BY REGION,

2018–2025 (USD MILLION)           73

6.2.3      LIQUID CHROMATOGRAPHY STANDARDS             73

6.2.3.1   HIGH SPEED, EFFICIENCY, AND ACCURACY OF LC TO SUPPLEMENT SEGMENT GROWTH  73

TABLE 13              LIQUID CHROMATOGRAPHY MARKET SIZE, BY REGION,

2018–2025 (USD MILLION)           73

6.2.4      THIN-LAYER CHROMATOGRAPHY             74

6.2.4.1   RAPID ANALYSIS TIME AND LOW SOLVENT CONSUMPTION TO DRIVE THE SEGMENT GROWTH   74

TABLE 14              THIN-LAYER CHROMATOGRAPHY MARKET SIZE, BY REGION,

2018–2025 (USD MILLION)           74

6.2.5      OTHER CHROMATOGRAPHY STANDARDS              74

TABLE 15              OTHER CHROMATOGRAPHY STANDARDS MARKET SIZE, BY REGION,

2018–2025 (USD MILLION)           74

 

6.3          SPECTROSCOPY                75

TABLE 16              SPECTROSCOPY MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)           75

TABLE 17              SPECTROSCOPY MARKET SIZE, BY REGION, 2018–2025 (USD MILLION)     76

TABLE 18              SPECTROSCOPY MARKET SIZE, BY CATEGORY, 2018–2025 (USD MILLION)               76

TABLE 19              SPECTROSCOPY MARKET SIZE, BY PRODUCT, 2018–2025 (USD MILLION) 76

TABLE 20              SPECTROSCOPY MARKET SIZE, BY METHODOLOGY,

2018–2025 (USD MILLION)           77

6.3.1      ATOMIC ABSORPTION SPECTROSCOPY  77

6.3.1.1   HIGH-THROUGHPUT AND INEXPENSIVE TECHNOLOGY TO IMPROVE THE ADOPTION OF AAS        77

TABLE 21              AAS STANDARDS MARKET SIZE, BY REGION, 2018–2025 (USD MILLION)  77

6.3.2      MASS SPECTROSCOPY   78

6.3.2.1   AUTOMATED TECHNIQUE WITH THE CAPABILITY TO HIGHLIGHT SPECIFIC METABOLITES OF DISEASE DRIVES THE MARKET GROWTH           78

TABLE 22              MASS SPECTROSCOPY MARKET SIZE, BY REGION,

2018–2025 (USD MILLION)           78

6.3.3      IR SPECTROSCOPY           78

6.3.3.1   THE HIGH ADOPTION OF IR SPECTROSCOPY TECHNIQUES AMONG RESEARCHERS & SCIENTISTS SUPPLEMENTS MARKET GROWTH           78

TABLE 23              IR SPECTROSCOPY MARKET SIZE, BY REGION, 2018–2025 (USD MILLION)                79

6.3.4      NUCLEAR MAGNETIC RESONANCE SPECTROMETRY         79

6.3.4.1   HIGH SPEED AND ACCURACY OF NMR TO DRIVE SEGMENT GROWTH       79

TABLE 24              NMR SPECTROMETRY MARKET SIZE, BY REGION, 2018–2025 (USD MILLION)         79

6.3.5      X-RAY FLUORESCENCE/DIFFRACTION SPECTROMETRY    80

6.3.5.1   LOW COST OF SAMPLE PREPARATION AND THE EASE OF USE OF X-RAY SPECTROMETERS TO FUEL SEGMENT GROWTH             80

TABLE 25              XRF SPECTROMETRY MARKET SIZE, BY REGION, 2018–2025 (USD MILLION)           80

6.3.6      UV/VISIBLE SPECTROSCOPY        80

6.3.6.1   QUICK ANALYTICAL RESPONSES OF THIS TECHNIQUE DRIVE MARKET GROWTH   80

TABLE 26              UV/VISIBLE SPECTROSCOPY MARKET SIZE, BY REGION,

2018–2025 (USD MILLION)           80

6.3.7      OTHER SPECTROSCOPY STANDARDS        81

TABLE 27              OTHER SPECTROSCOPY MARKET SIZE, BY REGION,

2018–2025 (USD MILLION)           81

6.4          TITRIMETRY        81

6.4.1      MARKET GROWTH IS MAINLY ATTRIBUTED TO THE INCREASING ADOPTION OF TITRIMETRIC ANALYSIS IN THE PHARMACEUTICAL INDUSTRY    81

TABLE 28              TITRIMETRY MARKET SIZE, BY REGION, 2018–2025 (USD MILLION)            82

TABLE 29              TITRIMETRY MARKET SIZE, BY CATEGORY, 2018–2025 (USD MILLION)       82

TABLE 30              TITRIMETRY MARKET SIZE, BY PRODUCT, 2018–2025 (USD MILLION)         82

TABLE 31              TITRIMETRY MARKET SIZE, BY METHODOLOGY, 2018–2025 (USD MILLION)            83

6.5          PHYSICAL PROPERTIES TESTING 83

6.5.1      INCREASING ADOPTION OF PPT STANDARDS IN QC PROCEDURES AND INSTRUMENT CALIBRATION DRIVES THE MARKET GROWTH           83

TABLE 32              PHYSICAL PROPERTY TESTING MARKET SIZE, BY TYPE,

2018–2025 (USD MILLION)           84

TABLE 33              PHYSICAL PROPERTY TESTING MARKET SIZE, BY REGION,

2018–2025 (USD MILLION)           84

TABLE 34              PHYSICAL PROPERTY TESTING MARKET SIZE, BY CATEGORY,

2018–2025 (USD MILLION)           84

TABLE 35              PHYSICAL PROPERTY TESTING MARKET SIZE, BY PRODUCT,

2018–2025 (USD MILLION)           85

TABLE 36              PHYSICAL PROPERTY TESTING MARKET SIZE, BY METHODOLOGY,

2018–2025 (USD MILLION)           85

6.5.2      VISCOSITY TESTING         85

6.5.2.1   STRINGENT REGULATIONS IMPLEMENTED ON THE QUALITY OF F&B TESTING TO DRIVE SEGMENT GROWTH        85

TABLE 37              VISCOSITY TESTING MARKET SIZE, BY REGION, 2018–2025 (USD MILLION)             86

6.5.3      SIEVE CALIBRATION & PARTICLE SIZE TESTING    86

6.5.3.1   INCREASING RESEARCH ACTIVITIES IN THE FIELD OF NANOTECHNOLOGY TO DRIVE SEGMENT GROWTH 86

TABLE 38              SIEVE CALIBRATION & PARTICLE SIZE TESTING MARKET SIZE, BY REGION, 2018–2025 (USD MILLION)        86

6.5.4      COLOR REFERENCE TESTING        87

6.5.4.1   INCREASING THE PRODUCTION OF PETROCHEMICAL PRODUCTS TO AID MARKET GROWTH          87

TABLE 39              COLOR REFERENCE MARKET SIZE, BY REGION, 2018–2025 (USD MILLION)              87

6.5.5      OTHER PHYSICAL PROPERTY TESTING STANDARDS            87

TABLE 40              OTHER PHYSICAL PROPERTY TESTING STANDARDS MARKET SIZE, BY REGION, 2018–2025 (USD MILLION)                87

7              ANALYTICAL STANDARDS MARKET, BY PRODUCT              88

7.1          INTRODUCTION                89

TABLE 41              ANALYTICAL STANDARDS MARKET SIZE, BY PRODUCT,

2018–2025 (USD MILLION)           89

7.2          FOOD & BEVERAGE ANALYTICAL STANDARDS     89

TABLE 42              ANALYTICAL STANDARDS MARKET SIZE FOR FOOD & BEVERAGE ANALYTICAL STANDARDS, BY TYPE, 2018-2025 (USD MILLION)       90

TABLE 43              ANALYTICAL STANDARDS MARKET SIZE FOR FOOD & BEVERAGE ANALYTICAL STANDARDS, BY REGION, 2018-2025 (USD MILLION)            90

7.2.1      FLAVOR & FRAGRANCE STANDARDS       91

7.2.1.1   DEVELOPMENT OF NOVEL PRODUCTS IN THE F&B AND COSMETIC INDUSTRIES TO FUEL THE GROWTH OF THIS SEGMENT            91

TABLE 44              FLAVOR & FRAGRANCE STANDARDS MARKET SIZE, BY REGION,

2018-2025 (USD MILLION)            91

7.2.2      CARBOHYDRATE STANDARDS     91

7.2.2.1   THE RISING NUMBER OF REGULATIONS FOR FOOD SAFETY & LABELING TO DRIVE THE GROWTH FOR CARBOHYDRATE STANDARDS     91

TABLE 45              CARBOHYDRATE STANDARDS MARKET SIZE, BY REGION,

2018-2025 (USD MILLION)            92

 

7.2.3      PEPTIDE/AMINO ACID STANDARDS         92

7.2.3.1   MANDATORY AMINO ACID ANALYSIS OF FOOD ITEMS TO FUEL SEGMENT GROWTH        92

TABLE 46              PEPTIDE/AMINO ACID STANDARDS MARKET SIZE, BY REGION,

2018-2025 (USD MILLION)            92

7.2.4      FOOD ADDITIVE STANDARDS      93

7.2.4.1   STRINGENT REGULATORY GUIDELINES TO CONTRIBUTE TO THE GROWTH OF THE FOOD ADDITIVE STANDARDS MARKET               93

TABLE 47              FOOD ADDITIVE STANDARDS MARKET SIZE, BY REGION,

2018-2025 (USD MILLION)            93

7.2.5      FATTY ACID/LIPID/FAME STANDARDS    93

7.2.5.1   NEW REGULATIONS RELATED TO THE LIMITATIONS OF TFA CONTENT TO DRIVE SEGMENT GROWTH        93

TABLE 48              FATTY ACID/LIPID/FAME STANDARDS MARKET SIZE, BY REGION,

2018-2025 (USD MILLION)            94

7.2.6      GMO (GENETICALLY MODIFIED ORGANISMS) STANDARDS           94

7.2.6.1   GROWING SAFETY AND REGULATORY CONCERNS RELATED TO GMOS DRIVES SEGMENT GROWTH            94

TABLE 49              GMO STANDARDS MARKET SIZE, BY REGION, 2018-2025 (USD MILLION)                94

7.2.7      MYCOTOXIN STANDARDS            95

7.2.7.1   REGULATIONS RELATED TO THE CONCENTRATION OF MYCOTOXIN IN EDIBLES TO FUEL SEGMENT GROWTH         95

TABLE 50              MYCOTOXIN: ANALYTICAL STANDARDS MARKET SIZE, BY REGION,

2018-2025 (USD MILLION)            95

7.3          FORENSIC ANALYTICAL STANDARDS        95

TABLE 51              ANALYTICAL STANDARDS MARKET SIZE FOR FORENSIC ANALYTICAL STANDARDS, BY TYPE, 2018-2025 (USD MILLION)             95

TABLE 52              ANALYTICAL STANDARDS MARKET SIZE FOR FORENSIC ANALYTICAL STANDARDS, BY REGION, 2018-2025 (USD MILLION) 96

7.3.1      DRUGS OF ABUSE STANDARDS  96

7.3.1.1   INCREASING USE OF DRUGS OF ABUSE TO FUEL SEGMENT GROWTH       96

TABLE 53              DRUGS OF ABUSE STANDARDS MARKET SIZE, BY REGION,

2018-2025 (USD MILLION)            96

7.3.2      DOPING STANDARDS     97

7.3.2.1   THE STRONG PRESENCE OF ANTI-DOPING REGULATIONS TO PROPEL MARKET GROWTH                97

TABLE 54              DOPING STANDARDS MARKET SIZE, BY REGION, 2018-2025 (USD MILLION)          97

7.4          VETERINARY DRUG ANALYTICAL STANDARDS     97

TABLE 55              ANALYTICAL STANDARDS MARKET SIZE FOR VETERINARY DRUG ANALYTICAL STANDARDS, BY TYPE, 2018-2025 (USD MILLION)       97

TABLE 56              ANALYTICAL STANDARDS MARKET SIZE FOR VETERINARY DRUG ANALYTICAL STANDARDS, BY REGION, 2018-2025 (USD MILLION)            98

7.4.1      ANTIBIOTIC STANDARDS              98

7.4.1.1   GOVERNMENT REGULATIONS FOR THE TESTING OF ANIMAL FOOD TO INCREASE THE ADOPTION OF ANTIBIOTIC STANDARDS       98

TABLE 57              ANTIBIOTIC STANDARDS MARKET SIZE, BY REGION,

2018-2025 (USD MILLION)            98

 

7.4.2      HORMONE STANDARDS                99

7.4.2.1   GROWING CONSUMER AWARENESS FOR THE DETECTION OF HARMFUL HORMONES TO FUEL SEGMENT GROWTH                99

TABLE 58              HORMONE STANDARDS MARKET SIZE, BY REGION,

2018-2025 (USD MILLION)            99

7.5          PETROCHEMISTRY ANALYTICAL STANDARDS       99

TABLE 59              ANALYTICAL STANDARDS MARKET SIZE FOR PETROCHEMISTRY ANALYTICAL STANDARDS, BY TYPE, 2018-2025 (USD MILLION)       100

TABLE 60              ANALYTICAL STANDARDS MARKET SIZE FOR PETROCHEMISTRY ANALYTICAL STANDARDS, BY REGION, 2018-2025 (USD MILLION)       100

7.5.1      GASOLINE, DIESEL, AND PETROLEUM STANDARDS           100

7.5.1.1   STRINGENT GOVERNMENT RULES RELATED TO AIR POLLUTION TO AID SEGMENT GROWTH         100

TABLE 61              GASOLINE, DIESEL, AND PETROLEUM STANDARDS MARKET SIZE, BY REGION, 2018-2025 (USD MILLION) 101

7.5.2      BIOFUEL STANDARDS     101

7.5.2.1   GROWING DEMAND FOR BIOFUELS TO INCREASE THE ADOPTION OF ANALYTICAL STANDARDS IN THIS SEGMENT                101

TABLE 62              BIOFUEL STANDARDS MARKET SIZE, BY REGION, 2018-2025 (USD MILLION)          101

7.6          ENVIRONMENTAL ANALYTICAL STANDARDS       102

TABLE 63              ANALYTICAL STANDARDS MARKET SIZE FOR ENVIRONMENTAL ANALYTICAL STANDARDS, BY TYPE, 2018-2025 (USD MILLION)       102

TABLE 64              ANALYTICAL STANDARDS MARKET SIZE FOR ENVIRONMENTAL ANALYTICAL STANDARDS, BY REGION, 2018-2025 (USD MILLION)       102

7.6.1      PESTICIDE STANDARDS  103

7.6.1.1   GUIDELINES FOR MONITORING OF PESTICIDES TO INCREASE THE MARKET SIZE  103

TABLE 65              PESTICIDE STANDARDS MARKET SIZE, BY REGION,

2018-2025 (USD MILLION)            103

7.6.2      VOLATILE & SEMI-VOLATILE STANDARDS              103

7.6.2.1   REGULATIONS MANDATING VOLATILE & SEMI-VOLATILE TESTING IN THE ENVIRONMENT TO FUEL MARKET GROWTH             103

TABLE 66              VOLATILE & SEMI-VOLATILE STANDARDS MARKET SIZE, BY REGION,

2018-2025 (USD MILLION)            104

7.6.3      FLAME RETARDANT STANDARDS              104

7.6.3.1   INCREASING ADOPTION OF FLAME RETARDANT STANDARDS WORLDWIDE DRIVES SEGMENT GROWTH 104

TABLE 67              FLAME RETARDANT STANDARDS MARKET SIZE, BY REGION,

2018-2025 (USD MILLION)            104

7.6.4      AROCLOR/PCB AND DIOXIN STANDARDS              105

7.6.4.1   STRICT GOVERNMENT REGULATION OWING TO RISKY EFFECTS STIMULATES THE ADOPTION OF PCB AND DIOXIN STANDARDS       105

TABLE 68              AROCLOR/PCB AND DIOXIN STANDARDS MARKET SIZE, BY REGION,

2018-2025 (USD MILLION)            105

7.6.5      ALKYLPHENOL STANDARDS         105

7.6.5.1   MULTIPLE APPLICATIONS OF ALKYLPHENOLS IN VARIOUS INDUSTRIES TO INCREASE THE MARKET SIZE   105

TABLE 69              ALKYLPHENOL STANDARDS MARKET SIZE, BY REGION,

2018-2025 (USD MILLION)            106

7.6.6      SOLID WASTE STANDARDS           106

7.6.6.1   INCREASING SOLID WASTE TESTING IN URBAN AREAS TO DRIVE SEGMENT GROWTH      106

TABLE 70              SOLID WASTE STANDARDS MARKET SIZE, BY REGION,

2018-2025 (USD MILLION)            106

7.7          PHARMACEUTICAL & LIFE SCIENCES ANALYTICAL STANDARDS    107

TABLE 71              ANALYTICAL STANDARDS MARKET SIZE FOR PHARMACEUTICAL & LIFE SCIENCES ANALYTICAL STANDARDS, BY TYPE, 2018-2025 (USD MILLION)          107

TABLE 72              ANALYTICAL STANDARDS MARKET SIZE FOR PHARMACEUTICAL & LIFE SCIENCE ANALYTICAL STANDARDS, BY REGION, 2018-2025 (USD MILLION)   107

7.7.1      COSMETIC STANDARDS 108

7.7.1.1   REGULATIONS RELATED TO MANUFACTURING & THE STORAGE OF COSMETICS TO DRIVE SEGMENT GROWTH    108

TABLE 73              COSMETIC STANDARDS MARKET SIZE, BY REGION,

2018-2025 (USD MILLION)            108

7.7.2      HERBAL DRUG/PHYTOPHARMACEUTICAL STANDARDS   108

7.7.2.1   INCREASING POPULARITY OF HERBAL DRUGS TO AID IN THE ADOPTION OF THESE STANDARDS  108

TABLE 74              HERBAL DRUG/PHYTOPHARMACEUTICAL STANDARDS MARKET SIZE,

BY REGION, 2018-2025 (USD MILLION)   109

7.7.3      PHARMACEUTICAL SECONDARY STANDARDS      109

7.7.3.1   RISING DRUG DEVELOPMENT TO PROPEL THE MARKET GROWTH OF PHARMACEUTICAL SECONDARY STANDARDS                109

TABLE 75              PHARMACEUTICAL SECONDARY STANDARDS MARKET SIZE, BY REGION, 2018-2025 (USD MILLION)           109

7.7.4      PHARMACEUTICAL IMPURITY REFERENCE STANDARDS  110

7.7.4.1   THE IDENTIFICATION OF IMPURITIES IN APIS TO INCREASE THE ADOPTION OF PHARMACEUTICAL REFERENCE STANDARDS       110

TABLE 76              PHARMACEUTICAL IMPURITY REFERENCE STANDARDS MARKET SIZE,

BY REGION, 2018-2025 (USD MILLION)   110

7.7.5      PHARMACOPOEIA STANDARDS 110

7.7.5.1   INCREASING R&D ACTIVITIES IN THE PHARMACEUTICAL INDUSTRY TO FUEL SEGMENT GROWTH               110

TABLE 77              PHARMACOPOEIA STANDARDS MARKET SIZE, BY REGION,

2018-2025 (USD MILLION)            111

7.7.6      FLUORESCENT MICROPARTICLE STANDARDS       111

7.7.6.1   INCREASING APPLICATIONS OF FLOW CYTOMETRY AND ELEMENTAL ANALYSIS TO FUEL SEGMENT GROWTH       111

TABLE 78              FLUORESCENT MICROPARTICLE STANDARDS MARKET SIZE, BY REGION, 2018-2025 (USD MILLION)            111

8              ANALYTICAL STANDARDS MARKET, BY METHODOLOGY  112

8.1          INTRODUCTION                113

TABLE 79              ANALYTICAL STANDARDS MARKET SIZE, BY METHODOLOGY,

2018–2025 (USD MILLION)           113

 

8.2          RAW MATERIAL TESTING              113

8.2.1      INCREASING MANUFACTURING OF MEDICINAL & PETROCHEMICAL PRODUCTS TO DRIVE MARKET GROWTH      113

TABLE 80              ANALYTICAL STANDARDS MARKET SIZE FOR RAW MATERIAL TESTING,

BY REGION, 2018–2025 (USD MILLION)  114

8.3          BIOANALYTICAL TESTING             114

8.3.1      RISING FOCUS ON THE ANALYTICAL TESTING OF BIOLOGICS AND BIOSIMILARS TO SUPPLEMENT MARKET GROWTH                114

TABLE 81              ANALYTICAL STANDARDS MARKET SIZE FOR BIOANALYTICAL TESTING,

BY REGION, 2018–2025 (USD MILLION)  114

8.4          STABILITY TESTING          115

8.4.1      INCREASING NUMBER OF CLINICAL TRIALS TO DRIVE THE MARKET GROWTH       115

TABLE 82              ANALYTICAL STANDARDS MARKET SIZE FOR STABILITY TESTING, BY REGION, 2018–2025 (USD MILLION) 115

8.5          DISSOLUTION TESTING  115

8.5.1      RISING PUBLIC-PRIVATE INVESTMENTS FOR VARIOUS RESEARCH ACTIVITIES TO DRIVE THE MARKET GROWTH   115

TABLE 83              ANALYTICAL STANDARDS MARKET SIZE FOR DISSOLUTION TESTING,

BY REGION, 2018–2025 (USD MILLION)  116

8.6          OTHER METHODOLOGIES             116

TABLE 84              ANALYTICAL STANDARDS MARKET SIZE FOR OTHER METHODOLOGIES,

BY REGION, 2018–2025 (USD MILLION)  116

9              ANALYTICAL STANDARDS MARKET, BY CATEGORY            117

9.1          INTRODUCTION                118

TABLE 85              ANALYTICAL STANDARDS MARKET SIZE, BY CATEGORY,

2018–2025 (USD MILLION)           118

9.2          ORGANIC ANALYTICAL STANDARDS        118

9.2.1      INCREASING DRUG DEVELOPMENT AND CLINICAL TRIAL ACTIVITIES IN THE LIFE SCIENCES INDUSTRY FUELS MARKET GROWTH OF ORGANIC ANALYTICAL STANDARDS              118

TABLE 86              ANALYTICAL STANDARDS MARKET SIZE FOR ORGANIC ANALYTICAL STANDARDS, BY REGION, 2018–2025 (USD MILLION) 119

9.3          INORGANIC ANALYTICAL STANDARDS    120

9.3.1      VARIOUS APPLICATIONS ACROSS FOOD & BEVERAGE, PHARMACEUTICALS, AND PETROCHEMICALS DRIVES THE MARKET GROWTH OF INORGANIC ANALYTICAL STANDARDS       120

TABLE 87              ANALYTICAL STANDARDS MARKET SIZE FOR INORGANIC ANALYTICAL STANDARDS, BY REGION, 2018–2025 (USD MILLION) 121

10           ANALYTICAL STANDARDS MARKET, BY REGION  122

10.1        INTRODUCTION                123

TABLE 88              ANALYTICAL STANDARDS MARKET SIZE, BY REGION,

2018–2025 (USD MILLION)           123

10.2        NORTH AMERICA             124

FIGURE 18           NORTH AMERICA: ANALYTICAL STANDARDS MARKET SNAPSHOT              124

TABLE 89              NORTH AMERICA: ANALYTICAL STANDARDS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)        125

TABLE 90              NORTH AMERICA: ANALYTICAL STANDARDS MARKET SIZE, BY CATEGORY, 2018–2025 (USD MILLION)      125

TABLE 91              NORTH AMERICA: ANALYTICAL STANDARDS MARKET SIZE, BY TECHNIQUE, 2018–2025 (USD MILLION)    125

TABLE 92              NORTH AMERICA: CHROMATOGRAPHY MARKET SIZE, BY TECHNIQUE,

2018–2025 (USD MILLION)           126

TABLE 93              NORTH AMERICA: SPECTROSCOPY MARKET SIZE, BY TECHNIQUE,

2018–2025 (USD MILLION)           126

TABLE 94              NORTH AMERICA: PHYSICAL PROPERTIES TESTING MARKET SIZE,

BY TECHNIQUE, 2018–2025 (USD MILLION)           126

TABLE 95              NORTH AMERICA: ANALYTICAL STANDARDS MARKET SIZE, BY PRODUCT, 2018–2025 (USD MILLION)        127

TABLE 96              NORTH AMERICA: ENVIRONMENTAL ANALYTICAL STANDARDS MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)             127

TABLE 97              NORTH AMERICA: PHARMACEUTICAL & LIFE SCIENCES ANALYTICAL STANDARDS MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)           128

TABLE 98              NORTH AMERICA: FOOD & BEVERAGE ANALYTICAL STANDARDS MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)             128

TABLE 99              NORTH AMERICA: FORENSIC ANALYTICAL STANDARDS MARKET SIZE,

BY TYPE, 2018–2025 (USD MILLION)         128

TABLE 100            NORTH AMERICA: VETERINARY DRUG ANALYTICAL STANDARDS MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)             129

TABLE 101            NORTH AMERICA: PETROCHEMISTRY ANALYTICAL STANDARDS MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)             129

TABLE 102            NORTH AMERICA: PHARMACEUTICAL & LIFE SCIENCES ANALYTICAL STANDARDS MARKET SIZE, BY METHODOLOGY, 2018–2025 (USD MILLION)        129

10.2.1    US          130

10.2.1.1                THE STRONG PRESENCE OF ANALYTICAL STANDARD MANUFACTURERS TO DRIVE MARKET GROWTH IN THE US          130

TABLE 103            US: ANALYTICAL STANDARDS MARKET SIZE, BY TECHNIQUE,

2018–2025 (USD MILLION)           131

TABLE 104            US: CHROMATOGRAPHY MARKET SIZE, BY TECHNIQUE,

2018–2025 (USD MILLION)           132

TABLE 105            US: SPECTROSCOPY MARKET SIZE, BY TECHNIQUE,

2018–2025 (USD MILLION)           132

TABLE 106            US: PHYSICAL PROPERTIES TESTING MARKET SIZE, BY TECHNIQUE,

2018–2025 (USD MILLION)           132

10.2.2    CANADA              133

10.2.2.1                AVAILABILITY OF GOVERNMENT FUNDING FOR RESEARCH AND INNOVATION TO DRIVE MARKET GROWTH IN CANADA        133

TABLE 107            CANADA: ANALYTICAL STANDARDS MARKET SIZE, BY TECHNIQUE,

2018–2025 (USD MILLION)           133

TABLE 108            CANADA: CHROMATOGRAPHY MARKET SIZE, BY TECHNIQUE,

2018–2025 (USD MILLION)           134

TABLE 109            CANADA: SPECTROSCOPY MARKET SIZE, BY TECHNIQUE,

2018–2025 (USD MILLION)           134

TABLE 110            CANADA: PHYSICAL PROPERTIES TESTING MARKET SIZE, BY TECHNIQUE, 2018–2025 (USD MILLION)         134

10.3        EUROPE               135

TABLE 111            EUROPE: ANALYTICAL STANDARDS MARKET SIZE, BY COUNTRY,

2018–2025 (USD MILLION)           136

TABLE 112            EUROPE: ANALYTICAL STANDARDS MARKET SIZE, BY CATEGORY,

2018–2025 (USD MILLION)           136

TABLE 113            EUROPE: ANALYTICAL STANDARDS MARKET SIZE, BY TECHNIQUE,

2018–2025 (USD MILLION)           137

TABLE 114            EUROPE: CHROMATOGRAPHY MARKET SIZE, BY TECHNIQUE,

2018–2025 (USD MILLION)           137

TABLE 115            EUROPE: SPECTROSCOPY MARKET SIZE, BY TECHNIQUE,

2018–2025 (USD MILLION)           137

TABLE 116            EUROPE: PHYSICAL PROPERTIES TESTING MARKET SIZE, BY TECHNIQUE, 2018–2025 (USD MILLION)          138

TABLE 117            EUROPE: ANALYTICAL STANDARDS MARKET SIZE, BY PRODUCT,

2018–2025 (USD MILLION)           138

TABLE 118            EUROPE: ENVIRONMENTAL ANALYTICAL STANDARDS MARKET SIZE,

BY PRODUCT, 2018–2025 (USD MILLION)               138

TABLE 119            EUROPE: PHARMACEUTICAL & LIFE SCIENCES ANALYTICAL STANDARDS MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION) 139

TABLE 120            EUROPE: FOOD & BEVERAGE ANALYTICAL STANDARDS MARKET SIZE,

BY TYPE, 2018–2025 (USD MILLION)         139

TABLE 121            EUROPE: FORENSIC ANALYTICAL STANDARDS MARKET SIZE, BY TYPE,

2018–2025 (USD MILLION)           139

TABLE 122            EUROPE: VETERINARY DRUG ANALYTICAL STANDARDS MARKET SIZE,

BY TYPE, 2018–2025 (USD MILLION)         140

TABLE 123            EUROPE: PETROCHEMISTRY ANALYTICAL STANDARDS MARKET SIZE,

BY TYPE, 2018–2025 (USD MILLION)         140

TABLE 124            EUROPE: PHARMACEUTICAL & LIFE SCIENCES ANALYTICAL STANDARDS MARKET SIZE, BY PRODUCT, 2018–2025 (USD MILLION)       140

10.3.1    GERMANY           141

10.3.1.1                GROWING BIOTECHNOLOGY SECTOR AND THE LARGE NUMBER OF ONGOING DRUG RESEARCH PROJECTS TO DRIVE MARKET GROWTH IN GERMANY           141

TABLE 125            GERMANY: ANALYTICAL STANDARDS MARKET SIZE, BY TECHNIQUE,

2018–2025 (USD MILLION)           142

TABLE 126            GERMANY: CHROMATOGRAPHY MARKET SIZE, BY PHYSICA,

2018–2025 (USD MILLION)           142

TABLE 127            GERMANY: SPECTROSCOPY MARKET SIZE, BY TECHNIQUE,

2018–2025 (USD MILLION)           142

TABLE 128            GERMANY: PHYSICAL PROPERTIES TESTING MARKET SIZE, BY TECHNIQUE, 2018–2025 (USD MILLION)      143

10.3.2    FRANCE                143

10.3.2.1                GEOGRAPHIC EXPANSION BY LIFE SCIENCE COMPANIES TO DRIVE MARKET GROWTH IN FRANCE              143

TABLE 129            FRANCE: ANALYTICAL STANDARDS MARKET SIZE, BY TECHNIQUE,

2018–2025 (USD MILLION)           144

TABLE 130            FRANCE: CHROMATOGRAPHY MARKET SIZE, BY TECHNIQUE,

2018–2025 (USD MILLION)           144

TABLE 131            FRANCE: SPECTROSCOPY MARKET SIZE, BY TECHNIQUE,

2018–2025 (USD MILLION)           145

TABLE 132            FRANCE: PHYSICAL PROPERTIES TESTING MARKET SIZE, BY TECHNIQUE, 2018–2025 (USD MILLION)           145

10.3.3    UK          145

10.3.3.1                HIGH USE OF ANALYTICAL TECHNIQUES IN FOOD TESTING AND GROWING R&D INVESTMENTS TO DRIVE MARKET GROWTH IN THE UK     145

TABLE 133            UK: ANALYTICAL STANDARDS MARKET SIZE, BY TECHNIQUE,

2018–2025 (USD MILLION)           147

TABLE 134            UK: CHROMATOGRAPHY MARKET SIZE, BY TECHNIQUE,

2018–2025 (USD MILLION)           147

TABLE 135            UK: SPECTROSCOPY MARKET SIZE, BY TECHNIQUE,

2018–2025 (USD MILLION)           147

TABLE 136            UK: PHYSICAL PROPERTIES TESTING MARKET SIZE, BY TECHNIQUE,

2018–2025 (USD MILLION)           148

10.3.4    ITALY     148

10.3.4.1                ADVANCEMENTS IN BIOTECHNOLOGY AND THE GROWING NUMBER OF BIOTECHNOLOGY FIRMS TO AID MARKET GROWTH IN ITALY         148

TABLE 137            ITALY: ANALYTICAL STANDARDS MARKET SIZE, BY TECHNIQUE,

2018–2025 (USD MILLION)           149

TABLE 138            ITALY: CHROMATOGRAPHY MARKET SIZE, BY TECHNIQUE,

2018–2025 (USD MILLION)           149

TABLE 139            ITALY: SPECTROSCOPY MARKET SIZE, BY TECHNIQUE,

2018–2025 (USD MILLION)           149

TABLE 140            ITALY: PHYSICAL PROPERTIES TESTING MARKET SIZE, BY TECHNIQUE,

2018–2025 (USD MILLION)           150

10.3.5    SPAIN   150

10.3.5.1                STRINGENT FOOD REGULATIONS & HIGH AGRICULTURAL IMPORT TO AID MARKET GROWTH IN SPAIN  150

TABLE 141            SPAIN: ANALYTICAL STANDARDS MARKET SIZE, BY TECHNIQUE,

2018–2025 (USD MILLION)           151

TABLE 142            SPAIN: CHROMATOGRAPHY MARKET SIZE, BY TECHNIQUE,

2018–2025 (USD MILLION)           151

TABLE 143            SPAIN: SPECTROSCOPY MARKET SIZE, BY TECHNIQUE,

2018–2025 (USD MILLION)           152

TABLE 144            SPAIN: PHYSICAL PROPERTIES TESTING MARKET SIZE, BY TECHNIQUE, 2018–2025 (USD MILLION)              152

10.3.6    REST OF EUROPE (ROE) 152

TABLE 145            ROE: ANALYTICAL STANDARDS MARKET SIZE, BY TECHNIQUE,

2018–2025 (USD MILLION)           153

TABLE 146            ROE: CHROMATOGRAPHY MARKET SIZE, BY TECHNIQUE,

2018–2025 (USD MILLION)           153

TABLE 147            ROE: SPECTROSCOPY MARKET SIZE, BY TECHNIQUE,

2018–2025 (USD MILLION)           154

TABLE 148            ROE: PHYSICAL PROPERTIES TESTING MARKET SIZE, BY TECHNIQUE,

2018–2025 (USD MILLION)           154

 

10.4        ASIA PACIFIC     155

FIGURE 19           ASIA PACIFIC: ANALYTICAL STANDARDS MARKET SNAPSHOT      156

TABLE 149            ASIA PACIFIC: ANALYTICAL STANDARDS MARKET SIZE, BY COUNTRY,

2018–2025 (USD MILLION)           157

TABLE 150            ASIA PACIFIC: ANALYTICAL STANDARDS MARKET SIZE, BY CATEGORY,

2018–2025 (USD MILLION)           157

TABLE 151            ASIA PACIFIC: ANALYTICAL STANDARDS MARKET SIZE, BY TECHNIQUE, 2018–2025 (USD MILLION)             157

TABLE 152            ASIA PACIFIC: CHROMATOGRAPHY MARKET SIZE, BY TECHNIQUE,

2018–2025 (USD MILLION)           158

TABLE 153            ASIA PACIFIC: SPECTROSCOPY MARKET SIZE, BY TECHNIQUE,

2018–2025 (USD MILLION)           158

TABLE 154            ASIA PACIFIC: PHYSICAL PROPERTIESTESTING MARKET SIZE, BY TECHNIQUE, 2018–2025 (USD MILLION) 158

TABLE 155            ASIA PACIFIC: ANALYTICAL STANDARDS MARKET SIZE, BY PRODUCT,

2018–2025 (USD MILLION)           159

TABLE 156            ASIA PACIFIC: ENVIRONMENTAL ANALYTICAL STANDARDS MARKET SIZE,

BY TYPE, 2018–2025 (USD MILLION)         159

TABLE 157            ASIA PACIFIC: PHARMACEUTICAL & LIFE SCIENCES ANALYTICAL STANDARDS MARKET SIZE, BY PRODUCT, 2018–2025 (USD MILLION)           160

TABLE 158            ASIA PACIFIC: FOOD & BEVERAGE ANALYTICAL STANDARDS MARKET SIZE,

BY TYPE, 2018–2025 (USD MILLION)         160

TABLE 159            ASIA PACIFIC: FORENSIC ANALYTICAL STANDARDS MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)      160

TABLE 160            ASIA PACIFIC: VETERINARY DRUG ANALYTICAL STANDARDS MARKET SIZE,

BY TYPE, 2018–2025 (USD MILLION)         161

TABLE 161            ASIA PACIFIC: PETROCHEMISTRY ANALYTICAL STANDARDS MARKET SIZE,

BY TYPE, 2018–2025 (USD MILLION)         161

TABLE 162            ASIA PACIFIC: PHARMACEUTICAL & LIFE SCIENCES ANALYTICAL STANDARDS MARKET SIZE, BY METHODOLOGY, 2018–2025 (USD MILLION)        161

10.4.1    JAPAN  162

10.4.1.1                RISING AWARENESS ABOUT ANALYTICAL TECHNOLOGIES TO SUPPLEMENT

THE MARKET GROWTH IN JAPAN              162

TABLE 163            JAPAN: ANALYTICAL STANDARDS MARKET SIZE, BY TECHNIQUE,

2018–2025 (USD MILLION)           162

TABLE 164            JAPAN: CHROMATOGRAPHY MARKET SIZE, BY TECHNIQUE,

2018–2025 (USD MILLION)           163

TABLE 165            JAPAN: SPECTROSCOPY MARKET SIZE, BY TECHNIQUE,

2018–2025 (USD MILLION)           163

TABLE 166            JAPAN: PHYSICAL PROPERTIES TESTING MARKET SIZE, BY TECHNIQUE, 2018–2025 (USD MILLION)             163

10.4.2    CHINA   164

10.4.2.1                GROWTH OF THE BIOTECHNOLOGY & PHARMACEUTICAL INDUSTRY AND INCREASING INVESTMENTS IN R&D ACTIVITIES TO DRIVE MARKET GROWTH      164

TABLE 167            CHINA: ANALYTICAL STANDARDS MARKET SIZE, BY TECHNIQUE,

2018–2025 (USD MILLION)           164

TABLE 168            CHINA: CHROMATOGRAPHY MARKET SIZE, BY TECHNIQUE,

2018–2025 (USD MILLION)           165

TABLE 169            CHINA: SPECTROSCOPY MARKET SIZE, BY TECHNIQUE,

2018–2025 (USD MILLION)           165

TABLE 170            CHINA: PHYSICAL PROPERTIES TESTING MARKET SIZE, BY TECHNIQUE, 2018–2025 (USD MILLION)              165

10.4.3    INDIA    166

10.4.3.1                INCREASING FOCUS ON SOIL TESTING IN INDIA AND GROWING FOOD SECURITY CONCERNS IN INDIA TO DRIVE MARKET GROWTH             166

TABLE 171            INDIA: ANALYTICAL STANDARDS MARKET SIZE, BY TECHNIQUE,

2018–2025 (USD MILLION)           166

TABLE 172            INDIA: CHROMATOGRAPHY MARKET SIZE, BY TECHNIQUE,

2018–2025 (USD MILLION)           167

TABLE 173            INDIA: SPECTROSCOPY MARKET SIZE, BY TECHNIQUE,

2018–2025 (USD MILLION)           167

TABLE 174            INDIA: PHYSICAL PROPERTIES TESTING MARKET SIZE, BY TECHNIQUE,

2018–2025 (USD MILLION)           167

10.4.4    AUSTRALIA         168

10.4.4.1                GROWING PUBLIC & PRIVATE INITIATIVES TO SUPPORT THE ADOPTION AND DEVELOPMENT OF ANALYTICAL TECHNOLOGIES      168

TABLE 175            AUSTRALIA: ANALYTICAL STANDARDS MARKET SIZE, BY TECHNIQUE,

2018–2025 (USD MILLION)           168

TABLE 176            AUSTRALIA: CHROMATOGRAPHY MARKET SIZE, BY TECHNIQUE,

2018–2025 (USD MILLION)           168

TABLE 177            AUSTRALIA: SPECTROSCOPY MARKET SIZE, BY TECHNIQUE,

2018–2025 (USD MILLION)           169

TABLE 178            AUSTRALIA: PHYSICAL PROPERTIES TESTING MARKET SIZE, BY TECHNIQUE, 2018–2025 (USD MILLION)    169

10.4.5    SOUTH KOREA   169

10.4.5.1                WIDE APPLICATIONS OF LIFE SCIENCE TECHNOLOGIES TO DRIVE THE MARKET GROWTH OF ANALYTICAL STANDARDS IN SOUTH KOREA   169

TABLE 179            SOUTH KOREA: ANALYTICAL STANDARDS MARKET SIZE, BY TECHNIQUE, 2018–2025 (USD MILLION)          170

TABLE 180            SOUTH KOREA: CHROMATOGRAPHY MARKET SIZE, BY TECHNIQUE,

2018–2025 (USD MILLION)           170

TABLE 181            SOUTH KOREA: SPECTROSCOPY MARKET SIZE, BY TECHNIQUE,

2018–2025 (USD MILLION)           171

TABLE 182            SOUTH KOREA: PHYSICAL PROPERTIES TESTING MARKET SIZE,

BY TECHNIQUE, 2018–2025 (USD MILLION)           171

10.4.6    REST OF ASIA PACIFIC (ROAPAC)              171

TABLE 183            ROAPAC: ANALYTICAL STANDARDS MARKET SIZE, BY TECHNIQUE,

2018–2025 (USD MILLION)           172

TABLE 184            ROAPAC: CHROMATOGRAPHY MARKET SIZE, BY TECHNIQUE,

2018–2025 (USD MILLION)           172

TABLE 185            ROAPAC: SPECTROSCOPY MARKET SIZE, BY TECHNIQUE,

2018–2025 (USD MILLION)           173

TABLE 186            ROAPAC: PHYSICAL PROPERTIES TESTING MARKET SIZE, BY TECHNIQUE, 2018–2025 (USD MILLION)          173

 

10.5        LATIN AMERICA                174

TABLE 187            LATIN AMERICA: ANALYTICAL STANDARDS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)           174

TABLE 188            LATIN AMERICA: ANALYTICAL STANDARDS MARKET SIZE, BY CATEGORY, 2018–2025 (USD MILLION)         174

TABLE 189            LATIN AMERICA: ANALYTICAL STANDARDS MARKET SIZE, BY TECHNIQUE, 2018–2025 (USD MILLION)       175

TABLE 190            LATIN AMERICA: CHROMATOGRAPHY MARKET SIZE, BY TECHNIQUE,

2018–2025 (USD MILLION)           175

TABLE 191            LATIN AMERICA: SPECTROSCOPY MARKET SIZE, BY TECHNIQUE,

2018–2025 (USD MILLION)           175

TABLE 192            LATIN AMERICA: PHYSICAL PROPERTIES TESTING MARKET SIZE,

BY TECHNIQUE, 2018–2025 (USD MILLION)           176

TABLE 193            LATIN AMERICA: ANALYTICAL STANDARDS MARKET SIZE, BY PRODUCT, 2018–2025 (USD MILLION)           176

TABLE 194            LATIN AMERICA: ENVIRONMENTAL ANALYTICAL STANDARDS MARKET SIZE, BY TYPE , 2018–2025 (USD MILLION)             176

TABLE 195            LATIN AMERICA: PHARMACEUTICAL & LIFE SCIENCES ANALYTICAL STANDARDS MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)           177

TABLE 196            LATIN AMERICA: FOOD & BEVERAGE ANALYTICAL STANDARDS MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)             177

TABLE 197            LATIN AMERICA: FORENSIC ANALYTICAL STANDARDS MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)                177

TABLE 198            LATIN AMERICA: VETERINARY DRUG ANALYTICAL STANDARDS MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)             178

TABLE 199            LATIN AMERICA: PETROCHEMISTRY ANALYTICAL STANDARDS MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)             178

TABLE 200            LATIN AMERICA: ANALYTICAL STANDARDS MARKET SIZE, BY METHODOLOGY, 2018–2025 (USD MILLION)                178

10.5.1    BRAZIL  179

10.5.1.1                INCREASING RESEARCH ACTIVITIES COUPLED WITH RISING PUBLIC & PRIVATE INITIATIVES TO AID THE MARKET GROWTH           179

TABLE 201            BRAZIL: ANALYTICAL STANDARDS MARKET SIZE, BY TECHNIQUE,

2018–2025 (USD MILLION)           179

TABLE 202            BRAZIL: CHROMATOGRAPHY MARKET SIZE, BY TECHNIQUE,

2018–2025 (USD MILLION)           180

TABLE 203            BRAZIL: SPECTROSCOPY MARKET SIZE, BY TECHNIQUE,

2018–2025 (USD MILLION)           180

TABLE 204            BRAZIL: PHYSICAL PROPERTIES TESTING MARKET SIZE, BY TECHNIQUE, 2018–2025 (USD MILLION)             180

10.5.2    MEXICO               181

10.5.2.1                PUBLIC-PRIVATE INVESTMENTS IN THE COUNTRY’S HEALTHCARE SYSTEMS TO AID MARKET GROWTH     181

TABLE 205            MEXICO: ANALYTICAL STANDARDS MARKET SIZE, BY TECHNIQUE,

2018–2025 (USD MILLION)           181

TABLE 206            MEXICO: CHROMATOGRAPHY MARKET SIZE, BY TECHNIQUE,

2018–2025 (USD MILLION)           182

TABLE 207            MEXICO: SPECTROSCOPY MARKET SIZE, BY TECHNIQUE,

2018–2025 (USD MILLION)           182

TABLE 208            MEXICO: PHYSICAL PROPERTIES TESTING MARKET SIZE, BY TECHNIQUE, 2018–2025 (USD MILLION)          182

10.5.3    REST OF LATIN AMERICA (ROLA)               183

TABLE 209            ROLA: ANALYTICAL STANDARDS MARKET SIZE, BY TECHNIQUE,

2018–2025 (USD MILLION)           183

TABLE 210            ROLA: CHROMATOGRAPHY MARKET SIZE, BY TECHNIQUE,

2018–2025 (USD MILLION)           183

TABLE 211            ROLA: SPECTROSCOPY MARKET SIZE, BY TECHNIQUE,

2018–2025 (USD MILLION)           184

TABLE 212            ROLA: PHYSICAL PROPERTIES TESTING MARKET SIZE, BY TECHNIQUE,

2018–2025 (USD MILLION)           184

10.6        MIDDLE EAST & AFRICA 184

TABLE 213            MEA: ANALYTICAL STANDARDS MARKET SIZE, BY CATEGORY,

2018–2025 (USD MILLION)           185

TABLE 214            MEA: ANALYTICAL STANDARDS MARKET SIZE, BY TECHNIQUE,

2018–2025 (USD MILLION)           185

TABLE 215            MEA: CHROMATOGRAPHY MARKET SIZE, BY TECHNIQUE,

2018–2025 (USD MILLION)           185

TABLE 216            MEA: SPECTROSCOPY MARKET SIZE, BY TECHNIQUE,

2018–2025 (USD MILLION)           186

TABLE 217            MEA: PHYSICAL PROPERTIES TESTING MARKET SIZE, BY TECHNIQUE,

2018–2025 (USD MILLION)           186

TABLE 218            MEA: ANALYTICAL STANDARDS MARKET SIZE, BY PRODUCT,

2018–2025 (USD MILLION)           186

TABLE 219            MEA: ENVIRONMENTAL ANALYTICAL STANDARDS MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)      187

TABLE 220            MEA: PHARMACEUTICAL & LIFE SCIENCES ANALYTICAL STANDARDS MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)             187

TABLE 221            MEA: FOOD & BEVERAGE ANALYTICAL STANDARDS MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)    188

TABLE 222            MEA: FORENSIC ANALYTICAL STANDARDS MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)       188

TABLE 223            MEA: VETERINARY DRUG ANALYTICAL STANDARDS MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)    188

TABLE 224            MEA: PETROCHEMISTRY ANALYTICAL STANDARDS MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)      189

TABLE 225            MEA: PHARMACEUTICAL & LIFE SCIENCES ANALYTICAL STANDARDS MARKET SIZE, BY METHODOLOGY, 2018–2025 (USD MILLION)           189

11           COMPETITIVE LANDSCAPE           190

11.1        OVERVIEW          190

FIGURE 20           KEY DEVELOPMENTS BY LEADING MARKET PLAYERS IN THE ANALYTICAL STANDARDS MARKET, 2016–2020                190

11.2        MARKET SHARE ANALYSIS            191

FIGURE 21           ANALYTICAL STANDARDS MARKET SHARE, BY KEY PLAYERS, 2020               191

11.3        COMPETITIVE SCENARIO              192

11.3.1    PRODUCT LAUNCHES, 2016–2020             192

11.3.2    AGREEMENTS AND COLLABORATIONS, 2015–2020           192

11.3.3    ACQUISITIONS, 2016–2020          192

11.3.4    EXPANSIONS, 2016–2020              193

11.4        COMPETITIVE LEADERSHIP MAPPING     193

11.4.1    STAR      193

11.4.2    EMERGING LEADERS      193

11.4.3    PERVASIVE         194

11.4.4    EMERGING COMPANIES               194

FIGURE 22           ANALYTICAL STANDARDS MARKET: GLOBAL COMPETITIVE LEADERSHIP MAPPING, 2019                194

12           COMPANY PROFILES      195

(BUSINESS OVERVIEW, PRODUCTS OFFERED, RECENT DEVELOPMENTS, MNM VIEW)*

12.1        MERCK KGAA    195

FIGURE 23           MERCK KGAA: COMPANY SNAPSHOT     195

12.2        AGILENT TECHNOLOGIES INC.    200

FIGURE 24           AGILENT TECHNOLOGIES INC.: COMPANY SNAPSHOT     200

12.3        WATERS CORPORATION               208

FIGURE 25           WATERS CORPORATION: COMPANY SNAPSHOT                208

12.4        RESTEK CORPORATION  212

12.5        SPEX CERTIPREP               215

12.6        ACCUSTANDARD INC.    217

12.7        LGC STANDARDS              218

FIGURE 26           LGC STANDARDS: COMPANY SNAPSHOT (2020) 218

12.8        PERKINELMER, INC.        222

FIGURE 27           PERKINELMER, INC.: COMPANY SNAPSHOT (2019)           222

12.9        THERMO FISHER SCIENTIFIC, INC.             224

FIGURE 28           THERMO FISCHER SCIENTIFIC: COMPANY SNAPSHOT (2019)        224

12.10     THE UNITED STATES PHARMACOPEIAL CONVENTION (USP)         226

FIGURE 29           THE UNITED STATES PHARMACOPEIAL CONVENTION: COMPANY SNAPSHOT (2019)         226

12.11     MALLINCKRODT               237

FIGURE 30           MALLINCKRODT: COMPANY SNAPSHOT (2019)  237

12.12     CAYMAN CHEMICAL COMPANY                239

12.13     RICCA CHEMICAL COMPANY       241

12.14     GFS CHEMICALS, INC.    242

12.15     CHIRON AS         243

*BUSINESS OVERVIEW, PRODUCTS OFFERED, RECENT DEVELOPMENTS, MNM VIEW MIGHT NOT BE CAPTURED IN CASE OF UNLISTED COMPANIES.

12.16     EMERGING PLAYERS       246

12.16.1  CAMBRIDGE ISOTOPE LABORATORIES    246

12.16.2  REAGECON DIAGNOSTICS LTD   247

12.16.3  CPI INTERNATIONAL       248

12.16.4  CRESCENT CHEMICAL     249

12.16.5  INORGANIC VENTURES 249

13           APPENDIX           250

13.1        DISCUSSION GUIDE        250

13.2        KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL   256

13.3        AVAILABLE CUSTOMIZATIONS   258

13.4        RELATED REPORTS           259

13.5        AUTHOR DETAILS             260

 

 

 

Pharmaceutical Packaging Equipment Market by Product (Aseptic Packaging, Blister, Strip, Bottle, Tube, Carton, Case Packer, Wrapping Machine, Palletiz...

Publisher:        MarketsandMarkets

# of Pages:        378

Rating: 

1 User License $4,950

Publication Date:  March, 2022

Price:       $4,950 / User License




1 INTRODUCTION 39
1.1 OBJECTIVES OF THE STUDY 39
1.2 MARKET DEFINITION 40
1.2.1 INCLUSIONS AND EXCLUSIONS 40
1.3 MARKET SCOPE 41
1.3.1 MARKETS COVERED 41
FIGURE 1 PHARMACEUTICAL PACKAGING EQUIPMENT MARKET SEGMENTATION 41
1.3.2 PHARMACEUTICAL PACKAGING EQUIPMENT MARKET: BY REGION 42
1.4 YEARS CONSIDERED FOR THE STUDY 42
1.5 CURRENCY 43
TABLE 1 STANDARD CURRENCY CONVERSION RATES 43
1.6 LIMITATIONS 43
1.7 STAKEHOLDERS 43
1.8 SUMMARY OF CHANGES 44
2 RESEARCH METHODOLOGY 45
2.1 RESEARCH DATA 45
FIGURE 2 RESEARCH DESIGN 45
2.1.1 SECONDARY DATA 46
2.1.1.1 Key data from secondary sources 47
2.1.2 PRIMARY DATA 48
FIGURE 3 PRIMARY SOURCES 48
2.1.2.1 Key data from primary sources 49
2.1.2.2 Key industry insights 50
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY SIDE AND DEMAND SIDE PARTICIPANTS 50
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION 51
FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION 51
2.2 MARKET SIZE ESTIMATION 52
FIGURE 7 SUPPLY SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 52
FIGURE 8 REVENUE SHARE ANALYSIS ILLUSTRATION: SYNTEGON TECHNOLOGY GMBH 53
FIGURE 9 SUPPLY SIDE MARKET SIZE ESTIMATION: PHARMACEUTICAL PACKAGING EQUIPMENT MARKET (2020) 54
FIGURE 10 APPROACH 3: BASED ON SOURCE, BY REGION (2022) 55
FIGURE 11 TOP-DOWN APPROACH 55
FIGURE 12 CAGR PROJECTIONS FROM DRIVERS, RESTRAINTS, OPPORTUNITIES,
AND CHALLENGES ANALYSIS (2022–2027) 57
FIGURE 13 CAGR PROJECTIONS: SUPPLY SIDE ANALYSIS 57
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 58
FIGURE 14 DATA TRIANGULATION METHODOLOGY 59
2.4 MARKET SHARE ESTIMATION 60
2.5 ASSUMPTIONS FOR THE STUDY 60
2.6 LIMITATIONS 60
2.6.1 METHODOLOGY-RELATED LIMITATIONS 61
2.7 RISK ASSESSMENT 61
TABLE 2 RISK ASSESSMENT: PHARMACEUTICAL PACKAGING EQUIPMENT MARKET 61
2.8 ASSESSMENT OF COVID-19 IMPACT ON ECONOMIC SCENARIO 61
3 EXECUTIVE SUMMARY 63
FIGURE 15 PHARMACEUTICAL PACKAGING EQUIPMENT MARKET, BY PRODUCT,
2022 VS. 2027 (USD MILLION) 63
FIGURE 16 PHARMACEUTICAL PACKAGING EQUIPMENT MARKET, BY TYPE,
2022 VS. 2027 (USD MILLION) 64
FIGURE 17 GEOGRAPHICAL SNAPSHOT OF PHARMACEUTICAL PACKAGING EQUIPMENT MARKET 65
4 PREMIUM INSIGHTS 66
4.1 PHARMACEUTICAL PACKAGING EQUIPMENT MARKET OVERVIEW 66
FIGURE 18 RISING NEED FOR FLEXIBLE AND INTEGRATED PACKAGING EQUIPMENT TO DRIVE MARKET GROWTH 66
4.2 ASIA PACIFIC: PHARMACEUTICAL PACKAGING EQUIPMENT MARKET,
BY PRODUCT AND COUNTRY (2021) 67
FIGURE 19 PRIMARY PACKAGING EQUIPMENT SEGMENT TO ACCOUNT FOR THE LARGEST SHARE OF APAC MARKET IN 2021 67
4.3 PHARMACEUTICAL PACKAGING EQUIPMENT MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 68
FIGURE 20 CHINA TO REGISTER THE HIGHEST GROWTH DURING FORECAST PERIOD 68
4.4 PHARMACEUTICAL PACKAGING EQUIPMENT MARKET, REGIONAL MIX, 2022−2027 68
FIGURE 21 EUROPE TO DOMINATE PHARMACEUTICAL PACKAGING EQUIPMENT MARKET 68
4.5 PHARMACEUTICAL PACKAGING EQUIPMENT MARKET: DEVELOPING VS. DEVELOPED MARKETS 69
FIGURE 22 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH DURING
FORECAST PERIOD 69
5 MARKET OVERVIEW 70
5.1 INTRODUCTION 70
5.2 MARKET DYNAMICS 70
FIGURE 23 PHARMACEUTICAL PACKAGING EQUIPMENT MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 70
5.2.1 DRIVERS 71
5.2.1.1 High growth in generics & biopharmaceuticals markets 71
FIGURE 24 SALES OF GENERIC DRUGS GLOBALLY, 2006–2020 (USD BILLION) 71
FIGURE 25 GLOBAL PHARMACEUTICALS MARKET (USD BILLION) 71
TABLE 3 LIST OF OFF-PATENT DRUGS, 2015−2029 72
5.2.1.2 Growing need for flexible and integrated packaging equipment 73
5.2.1.3 Increase in offshore pharmaceutical manufacturing 73
FIGURE 26 PHARMACEUTICAL IMPORTS AND EXPORTS, BY COUNTRY,
2020 (USD BILLION) 74
5.2.1.4 Growing contract manufacturing of pharmaceutical products 74
5.2.1.5 Introduction of regulatory standards on packaging and stringent norms against counterfeit products 74
TABLE 4 KEY REGULATIONS & STANDARDS GOVERNING PHARMACEUTICAL PACKAGING EQUIPMENT 75
5.2.1.6 Innovation in pharmaceutical packaging and delivery system 75
5.2.1.7 Growth in OTC drug sales and regulations to reduce OTC counterfeit 76
FIGURE 27 GLOBAL OTC PHARMACEUTICALS MARKET SIZE, 2020 (USD BILLION) 76
5.2.2 RESTRAINTS 76
5.2.2.1 Growing preference for refurbished equipment 76
5.2.3 OPPORTUNITIES 77
5.2.3.1 Growth of pharmaceutical manufacturing in emerging economies 77
5.2.3.2 Rising demand for automated packaging 77
5.2.3.3 Change in medication systems to self-medication and self-care 78
5.2.3.4 Increasing pharmaceutical R&D investments 78
FIGURE 28 PHARMACEUTICAL & BIOPHARMACEUTICAL R&D EXPENDITURE,
2017–2024 79
FIGURE 29 NUMBER OF REGISTERED STUDIES, 2001-2022
(AS OF FEBRUARY 22, 2022) 79
FIGURE 30 NUMBER OF PIPELINE DRUGS, BY COMPANY, 2019 80
5.2.4 CHALLENGES 80
5.2.4.1 Growth in personalized and precision medicine supply chain 80
5.2.4.2 Uncertainties in regulations and standards of pharmaceutical packaging process 81
5.3 TECHNOLOGICAL ROADMAP 82
FIGURE 31 PHARMACEUTICAL PACKAGING EQUIPMENT: TECHNOLOGICAL ROADMAP 82
5.4 INDUSTRY TRENDS 83
FIGURE 32 MAJOR TRENDS IN PHARMACEUTICAL PACKAGING EQUIPMENT MARKET 83
5.4.1 DEVELOPMENT OF PRODUCTION LINES FOR SMALL BATCH SIZES AND RESEARCH PURPOSES 83
5.4.2 AUTOMATION AND INTEGRATION OF PACKAGING EQUIPMENT 84
5.4.3 GROWING FOCUS ON LABELING AND SERIALIZATION FOR ANTI-COUNTERFEITING OF DRUGS 85
5.4.4 GROWING DEMAND FOR ASEPTIC FILLING AND SEALING EQUIPMENT 85
5.5 PRICING ANALYSIS 86
TABLE 5 AVERAGE SELLING PRICE (USD): PRIMARY PACKAGING EQUIPMENT 86
TABLE 6 AVERAGE SELLING PRICE (USD): SECONDARY PACKAGING EQUIPMENT 87
TABLE 7 AVERAGE SELLING PRICE (USD): LABELING AND SERIALIZATION EQUIPMENT 87
5.6 SUPPLY CHAIN ANALYSIS 87
FIGURE 33 SUPPLY CHAIN ANALYSIS 88
5.7 VALUE CHAIN ANALYSIS 88
FIGURE 34 VALUE CHAIN OF PHARMACEUTICAL PACKAGING EQUIPMENT MARKET 89
5.8 ECOSYSTEM MARKET MAP 89
FIGURE 35 PHARMACEUTICAL PACKAGING EQUIPMENT MARKET:
ECOSYSTEM MARKET MAP 89
5.9 PORTER’S FIVE FORCES ANALYSIS 90
TABLE 8 PHARMACEUTICAL PACKAGING EQUIPMENT MARKET: PORTER’S FIVE FORCES ANALYSIS 90
5.10 REGULATORY ANALYSIS 92
5.10.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 92
TABLE 9 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 92
TABLE 10 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 92
TABLE 11 ASIA-PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 93
TABLE 12 REST OF WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 93
5.10.2 NORTH AMERICA 94
5.10.2.1 US 94
5.10.2.2 CANADA 94
5.10.3 EUROPE 95
5.10.4 ASIA PACIFIC 95
5.10.4.1 Japan 95
5.10.4.2 China 95
5.10.4.3 India 95
5.10.5 BRAZIL 96
FIGURE 36 BRAZIL: REGULATORY PROCESS FOR PHARMACEUTICAL PACKAGING EQUIPMENT 96
5.11 KEY CONFERENCES & EVENTS IN 2022-2023 97
TABLE 13 PHARMACEUTICAL PACKAGING EQUIPMENT MARKET: DETAILED LIST OF CONFERENCES & EVENTS 97
5.12 YC–YCC TRENDS/DISRUPTION IMPACTING CUSTOMER BUSINESS 98
FIGURE 37 YC–YCC SHIFT IN PHARMACEUTICAL PACKAGING EQUIPMENT MARKET 98
5.13 PATENT ANALYSIS 98
5.13.1 PATENT PUBLICATION TRENDS FOR PHARMACEUTICAL PACKAGING EQUIPMENT 98
FIGURE 38 GLOBAL PATENT PUBLICATION TRENDS IN PHARMACEUTICAL PACKAGING EQUIPMENT MARKET, 2015–2021 99
5.13.2 JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR PATENTS IN PHARMACEUTICAL PACKAGING EQUIPMENT MARKET 99
FIGURE 39 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR PHARMACEUTICAL PACKAGING EQUIPMENT PATENTS,
2015–2021 99
5.14 TRADE ANALYSIS 100
TABLE 14 PHARMACEUTICAL PACKAGING EQUIPMENT EXPORT AND IMPORT DATA,
BY COUNTRY 100
5.15 CASE STUDY ANALYSIS 101
FIGURE 40 CASE STUDY: SECURITY PACKAGING UPGRADES FOR PHARMACEUTICAL 101
5.15.1 CASE STUDY: QUALITATIVE INSIGHT BASED ON SPEED OF THE MACHINE 102
5.15.1.1 Sachet packaging equipment: 102
5.15.1.2 Blister packaging equipment: 102
5.15.1.3 Cartoning equipment: 104
5.16 IMPACT OF COVID-19 ON PHARMACEUTICAL PACKAGING EQUIPMENT MARKET 107
6 PHARMACEUTICAL PACKAGING EQUIPMENT MARKET, BY PRODUCT 109
6.1 INTRODUCTION 110
TABLE 15 PHARMACEUTICAL PACKAGING EQUIPMENT MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 110
6.2 PRIMARY PACKAGING EQUIPMENT 110
TABLE 16 PRIMARY PACKAGING EQUIPMENT MARKET, BY TYPE,
2020–2027 (USD MILLION) 111
TABLE 17 PRIMARY PACKAGING EQUIPMENT MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 112
6.2.1 ASEPTIC FILLING AND SEALING EQUIPMENT 112
6.2.1.1 Technological advancements and automation to drive segment growth 112
TABLE 18 EXAMPLES OF ASEPTIC FILLING AND SEALING EQUIPMENT 113
TABLE 19 ASEPTIC FILLING AND SEALING EQUIPMENT MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 116
6.2.2 BOTTLE FILLING AND CAPPING EQUIPMENT 116
6.2.2.1 Higher adoption of plastic bottles in pharmaceutical packaging to support segment growth 116
TABLE 20 EXAMPLES OF BOTTLE FILLING AND CAPPING EQUIPMENT 117
TABLE 21 BOTTLE FILLING AND CAPPING EQUIPMENT MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 118
6.2.3 BLISTER PACKAGING EQUIPMENT 118
6.2.3.1 Adaptability of blister packs to impact blister packaging equipment demand 118
TABLE 22 EXAMPLES OF BLISTER PACKAGING EQUIPMENT 119
TABLE 23 BLISTER PACKAGING EQUIPMENT MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 121
6.2.4 SOFT-TUBE FILLING AND SEALING EQUIPMENT 122
6.2.4.1 Increasing demand for soft-tube-based drug formulations and OTC pain relief ointments and creams to aid market growth 122
TABLE 24 EXAMPLES OF SOFT-TUBE FILLING AND SEALING EQUIPMENT 122
TABLE 25 SOFT-TUBE FILLING AND SEALING EQUIPMENT MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 123
6.2.5 SACHET PACKAGING EQUIPMENT 124
6.2.5.1 Increasing applications of sachets and pouches in unit dose packaging to drive segment growth 124
TABLE 26 EXAMPLES OF SACHET PACKAGING EQUIPMENT 124
TABLE 27 SACHET PACKAGING EQUIPMENT MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 125
6.2.6 STRIP PACKAGING EQUIPMENT 125
6.2.6.1 User-friendly packaging of strips to drive segment growth 125
TABLE 28 EXAMPLES OF STRIP PACKAGING EQUIPMENT 126
TABLE 29 STRIP PACKAGING EQUIPMENT MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 127
6.2.7 COUNTING EQUIPMENT 127
6.2.7.1 Initiatives to develop remote tablet counting machines to improve accuracy and efficiency in medical dispensing 127
TABLE 30 EXAMPLES OF COUNTING EQUIPMENT 128
TABLE 31 COUNTING EQUIPMENT MARKET, BY COUNTRY, 2020–2027(USD MILLION) 129
6.2.8 OTHER PRIMARY PACKAGING EQUIPMENT 129
TABLE 32 OTHER PRIMARY PACKAGING EQUIPMENT MARKET, BY COUNTRY,
2020–2027(USD MILLION) 130
6.3 SECONDARY PACKAGING EQUIPMENT 130
TABLE 33 SECONDARY PACKAGING EQUIPMENT MARKET, BY TYPE,
2020–2027 (USD MILLION) 131
TABLE 34 SECONDARY PACKAGING EQUIPMENT MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 132
6.3.1 CARTONING EQUIPMENT 132
6.3.1.1 Safe and gentle packaging achieved with cartoning equipment usage to drive segment growth 132
TABLE 35 EXAMPLES OF CARTONING EQUIPMENT 133
TABLE 36 CARTONING EQUIPMENT MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 135
6.3.2 CASE PACKING EQUIPMENT 135
6.3.2.1 Increasing demand for flexible packaging to support market growth 135
TABLE 37 EXAMPLES OF CASE PACKING EQUIPMENT 136
TABLE 38 CASE PACKING EQUIPMENT MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 137
6.3.3 WRAPPING EQUIPMENT 137
6.3.3.1 Wrapping machines offer customization to increase productivity 137
TABLE 39 EXAMPLES OF WRAPPING EQUIPMENT 138
TABLE 40 WRAPPING EQUIPMENT MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 139
6.3.4 TRAY PACKING EQUIPMENT 139
6.3.4.1 Technological advances to support segment growth 139
TABLE 41 EXAMPLES OF TRAY PACKING EQUIPMENT 140
TABLE 42 TRAY PACKING EQUIPMENT MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 140
6.3.5 PALLETIZING AND DEPALLETIZING EQUIPMENT 141
6.3.5.1 Recent developments and automation in palletizing and depalletizing equipment to drive market growth 141
TABLE 43 EXAMPLES OF PALLETIZING AND DEPALLETIZING EQUIPMENT 141
TABLE 44 PALLETIZING AND DEPALLETIZING EQUIPMENT MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 142
6.4 LABELING AND SERIALIZATION EQUIPMENT 142
TABLE 45 LABELING AND SERIALIZATION EQUIPMENT MARKET, BY TYPE,
2020–2027 (USD MILLION) 143
TABLE 46 LABELING AND SERIALIZATION EQUIPMENT MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 144
6.4.1 BOTTLE AND AMPOULE LABELING AND SERIALIZATION EQUIPMENT 144
6.4.1.1 Increasing awareness about anti-counterfeit technologies to drive market growth 144
TABLE 47 EXAMPLES OF BOTTLE AND AMPOULE LABELING AND SERIALIZATION EQUIPMENT 145
TABLE 48 BOTTLE AND AMPOULE LABELING AND SERIALIZATION EQUIPMENT MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 146
6.4.2 CARTON LABELING AND SERIALIZATION EQUIPMENT 146
6.4.2.1 Increasing demand for pharmaceutical products labeling and serialization to drive market growth 146
TABLE 49 EXAMPLES OF CARTON LABELING AND SERIALIZATION EQUIPMENT 147
TABLE 50 CARTON LABELING AND SERIALIZATION EQUIPMENT MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 147
6.4.3 DATA MATRIX LABELING AND SERIALIZATION EQUIPMENT 148
6.4.3.1 Speed and ease of use to propel segment growth 148
TABLE 51 EXAMPLES OF DATA MATRIX LABELING AND SERIALIZATION EQUIPMENT 148
TABLE 52 DATA MATRIX LABELING AND SERIALIZATION EQUIPMENT MARKET,
BY COUNTRY, 2020–2027 (USD MILLION) 149
7 PHARMACEUTICAL PACKAGING EQUIPMENT MARKET, BY TYPE 150
7.1 INTRODUCTION 151
TABLE 53 PHARMACEUTICAL PACKAGING EQUIPMENT MARKET, BY TYPE,
2020–2027 (USD MILLION) 151
7.2 LIQUID PACKAGING EQUIPMENT 151
TABLE 54 LIQUID PACKAGING EQUIPMENT MARKET, BY TYPE,
2020–2027 (USD MILLION) 152
TABLE 55 LIQUID PACKAGING EQUIPMENT MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 152
7.2.1 ASEPTIC LIQUIDS 153
7.2.1.1 Automation of packaging lines and increasing use of robotics to propel aseptic liquid packaging 153
TABLE 56 EXAMPLES OF ASEPTIC LIQUID PACKAGING EQUIPMENT 154
TABLE 57 ASEPTIC LIQUID PACKAGING EQUIPMENT MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 157
7.2.2 SYRUPS 158
7.2.2.1 Bottle filling and capping machines to reduce syrup spillage risk 158
TABLE 58 EXAMPLES OF SYRUP PACKAGING EQUIPMENT 158
TABLE 59 SYRUP PACKAGING EQUIPMENT MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 159
7.2.3 EYE/EAR DROPS 159
7.2.3.1 Technological advancements to increase demand for automated form-fill-seal equipment used for eye/ear drops packaging 159
TABLE 60 EXAMPLES OF EYE/EAR DROP PACKAGING EQUIPMENT 160
TABLE 61 EYE/EAR DROP PACKAGING EQUIPMENT MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 160
7.2.4 AEROSOLS 161
7.2.4.1 Integration of filling and sealing processes to gain importance in aerosol packaging 161
TABLE 62 EXAMPLES OF AEROSOL PACKAGING EQUIPMENT 161
TABLE 63 AEROSOL PACKAGING EQUIPMENT MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 162
7.2.5 OTHER LIQUID PACKAGING EQUIPMENT 162
TABLE 64 OTHER LIQUID PACKAGING EQUIPMENT MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 163
7.3 SOLID PACKAGING EQUIPMENT 163
TABLE 65 SOLID PACKAGING EQUIPMENT MARKET, BY TYPE,
2020–2027 (USD MILLION) 164
TABLE 66 SOLID PACKAGING EQUIPMENT MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 164
7.3.1 TABLETS 165
7.3.1.1 Growing demand for packaging equipment capable of handling smaller batch sizes with higher levels of accuracy and precision to drive segment growth 165
TABLE 67 EXAMPLES OF TABLET PACKAGING EQUIPMENT 165
TABLE 68 TABLET PACKAGING EQUIPMENT MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 168
7.3.2 CAPSULES 168
7.3.2.1 Capsule-counting machines to integrate with filling and inspection systems 168
TABLE 69 EXAMPLES OF CAPSULE PACKAGING EQUIPMENT 169
TABLE 70 CAPSULE PACKAGING EQUIPMENT MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 170
7.3.3 POWDERS 170
7.3.3.1 High demand for robotic packaging equipment for powder packaging to proper segment growth 170
TABLE 71 EXAMPLES OF POWDER PACKAGING EQUIPMENT 171
TABLE 72 POWDER PACKAGING EQUIPMENT MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 172
7.3.4 GRANULES 172
7.3.4.1 Sachets to become most preferred packaging forms for granules 172
TABLE 73 EXAMPLES OF GRANULE PACKAGING EQUIPMENT 173
TABLE 74 GRANULE PACKAGING EQUIPMENT MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 173
7.3.5 OTHER SOLID PACKAGING EQUIPMENT 174
TABLE 75 OTHER SOLID PACKAGING EQUIPMENT MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 174
7.4 SEMI-SOLID PACKAGING EQUIPMENT 175
TABLE 76 SEMI-SOLID PACKAGING EQUIPMENT MARKET, BY TYPE,
2020–2027 (USD MILLION) 175
TABLE 77 SEMI-SOLID PACKAGING EQUIPMENT MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 176
7.4.1 OINTMENTS 176
7.4.1.1 Wide usage to drive pharmaceutical packaging equipment demand 176
TABLE 78 EXAMPLES OF OINTMENT PACKAGING EQUIPMENT 177
TABLE 79 OINTMENT PACKAGING EQUIPMENT MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 178
7.4.2 CREAMS 178
7.4.2.1 Filling, capping, and sealing machines to package creams 178
TABLE 80 CREAM PACKAGING EQUIPMENT MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 179
7.4.3 SUPPOSITORIES 179
7.4.3.1 Drying drug pipelines and growing costs to limit segment growth 179
TABLE 81 SUPPOSITORY PACKAGING EQUIPMENT MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 180
7.4.4 OTHER SEMI-SOLID PACKAGING EQUIPMENT 180
TABLE 82 OTHER SEMI-SOLID PACKAGING EQUIPMENT MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 181
7.5 OTHER PRODUCT PACKAGING EQUIPMENT 181
TABLE 83 OTHER PRODUCT PACKAGING EQUIPMENT MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 182
8 PHARMACEUTICAL PACKAGING EQUIPMENT MARKET, BY REGION 183
8.1 INTRODUCTION 184
FIGURE 41 PHARMACEUTICAL PACKAGING EQUIPMENT MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 184
TABLE 84 PHARMACEUTICAL PACKAGING EQUIPMENT MARKET, BY REGION,
2020–2027 (USD MILLION) 185
8.2 EUROPE 185
FIGURE 42 EUROPE: PHARMACEUTICAL PACKAGING EQUIPMENT MARKET SNAPSHOT 186
TABLE 85 EUROPE: PHARMACEUTICAL PACKAGING EQUIPMENT MARKET,
BY COUNTRY, 2020–2027 (USD MILLION) 187
TABLE 86 EUROPE: PHARMACEUTICAL PACKAGING EQUIPMENT MARKET,
BY PRODUCT, 2020–2027 (USD MILLION) 187
TABLE 87 EUROPE: PRIMARY PACKAGING EQUIPMENT MARKET, BY TYPE,
2020–2027 (USD MILLION) 188
TABLE 88 EUROPE: SECONDARY PACKAGING EQUIPMENT MARKET, BY TYPE,
2020–2027 (USD MILLION) 188
TABLE 89 EUROPE: LABELING AND SERIALIZATION EQUIPMENT MARKET,
BY TYPE, 2020–2027 (USD MILLION) 189
TABLE 90 EUROPE: PHARMACEUTICAL PACKAGING EQUIPMENT MARKET, BY TYPE, 2020–2027 (USD MILLION) 189
TABLE 91 EUROPE: LIQUID PACKAGING EQUIPMENT MARKET, BY TYPE,
2020–2027 (USD MILLION) 190
TABLE 92 EUROPE: SOLID PACKAGING EQUIPMENT MARKET, BY TYPE,
2020–2027 (USD MILLION) 190
TABLE 93 EUROPE: SEMI-SOLID PACKAGING EQUIPMENT MARKET, BY TYPE,
2020–2027 (USD MILLION) 191
8.2.1 GERMANY 191
8.2.1.1 Germany to witness highest growth rate in European market 191
TABLE 94 GERMANY: KEY MACROINDICATORS 192
TABLE 95 GERMANY: PHARMACEUTICAL PACKAGING EQUIPMENT MARKET,
BY PRODUCT, 2020–2027 (USD MILLION) 192
TABLE 96 GERMANY: PRIMARY PACKAGING EQUIPMENT MARKET, BY TYPE,
2020–2027 (USD MILLION) 193
TABLE 97 GERMANY: SECONDARY PACKAGING EQUIPMENT MARKET, BY TYPE,
2020–2027 (USD MILLION) 193
TABLE 98 GERMANY: LABELING AND SERIALIZATION EQUIPMENT MARKET,
BY TYPE, 2020–2027 (USD MILLION) 194
TABLE 99 GERMANY: PHARMACEUTICAL PACKAGING EQUIPMENT MARKET,
BY TYPE, 2020–2027 (USD MILLION) 194
TABLE 100 GERMANY: LIQUID PACKAGING EQUIPMENT MARKET, BY TYPE,
2020–2027 (USD MILLION) 195
TABLE 101 GERMANY: SOLID PACKAGING EQUIPMENT MARKET, BY TYPE,
2020–2027 (USD MILLION) 195
TABLE 102 GERMANY: SEMI-SOLID PACKAGING EQUIPMENT MARKET, BY TYPE,
2020–2027 (USD MILLION) 196
8.2.2 ITALY 196
8.2.2.1 Growing consumption of OTC and generic drugs to drive market growth 196
TABLE 103 ITALY: KEY MACROINDICATORS 197
TABLE 104 ITALY: PHARMACEUTICAL PACKAGING EQUIPMENT MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 197
TABLE 105 ITALY: PRIMARY PACKAGING EQUIPMENT MARKET, BY TYPE,
2020–2027 (USD MILLION) 198
TABLE 106 ITALY: SECONDARY PACKAGING EQUIPMENT MARKET, BY TYPE,
2020–2027 (USD MILLION) 198
TABLE 107 ITALY: LABELING AND SERIALIZATION EQUIPMENT MARKET, BY TYPE,
2020–2027 (USD MILLION) 199
TABLE 108 ITALY: PHARMACEUTICAL PACKAGING EQUIPMENT MARKET, BY TYPE,
2020–2027 (USD MILLION) 199
TABLE 109 ITALY: LIQUID PACKAGING EQUIPMENT MARKET, BY TYPE,
2020–2027 (USD MILLION) 200
TABLE 110 ITALY: SOLID PACKAGING EQUIPMENT MARKET, BY TYPE,
2020–2027 (USD MILLION) 200
TABLE 111 ITALY: SEMI-SOLID PACKAGING EQUIPMENT MARKET, BY TYPE,
2020–2027 (USD MILLION) 201
8.2.3 UK 201
8.2.3.1 Growth in generics market alongside rising demand for prescription and OTC drugs to drive market growth 201
TABLE 112 UK: KEY MACROINDICATORS 201
TABLE 113 UK: PHARMACEUTICAL PACKAGING EQUIPMENT MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 202
TABLE 114 UK: PRIMARY PACKAGING EQUIPMENT MARKET, BY TYPE,
2020–2027 (USD MILLION) 202
TABLE 115 UK: SECONDARY PACKAGING EQUIPMENT MARKET, BY TYPE,
2020–2027 (USD MILLION) 203
TABLE 116 UK: LABELING AND SERIALIZATION EQUIPMENT MARKET, BY TYPE,
2020–2027 (USD MILLION) 203
TABLE 117 UK: PHARMACEUTICAL PACKAGING EQUIPMENT MARKET, BY TYPE,
2020–2027 (USD MILLION) 204
TABLE 118 UK: LIQUID PACKAGING EQUIPMENT MARKET, BY TYPE,
2020–2027 (USD MILLION) 204
TABLE 119 UK: SOLID PACKAGING EQUIPMENT MARKET, BY TYPE,
2020–2027 (USD MILLION) 205
TABLE 120 UK: SEMI-SOLID PACKAGING EQUIPMENT MARKET, BY TYPE,
2020–2027 (USD MILLION) 205
8.2.4 FRANCE 206
8.2.4.1 Presence of leading pharmaceutical companies to drive market growth 206
TABLE 121 FRANCE: KEY MACROINDICATORS 206
TABLE 122 FRANCE: PHARMACEUTICAL PACKAGING EQUIPMENT MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 206
TABLE 123 FRANCE: PRIMARY PACKAGING EQUIPMENT MARKET, BY TYPE,
2020–2027 (USD MILLION) 207
TABLE 124 FRANCE: SECONDARY PACKAGING EQUIPMENT MARKET, BY TYPE,
2020–2027 (USD MILLION) 207
TABLE 125 FRANCE: LABELING AND SERIALIZATION EQUIPMENT MARKET,
BY TYPE, 2020–2027 (USD MILLION) 208
TABLE 126 FRANCE: PHARMACEUTICAL PACKAGING EQUIPMENT MARKET,
BY TYPE, 2020–2027 (USD MILLION) 208
TABLE 127 FRANCE: LIQUID PACKAGING EQUIPMENT MARKET, BY TYPE,
2020–2027 (USD MILLION) 209
TABLE 128 FRANCE: SOLID PACKAGING EQUIPMENT MARKET, BY TYPE,
2020–2027 (USD MILLION) 209
TABLE 129 FRANCE: SEMI-SOLID PACKAGING EQUIPMENT MARKET, BY TYPE,
2020–2027 (USD MILLION) 210
8.2.5 SPAIN 210
8.2.5.1 Rising geriatric population and growing generics market to propel market growth 210
TABLE 130 SPAIN: KEY MACROINDICATORS 211
TABLE 131 SPAIN: PHARMACEUTICAL PACKAGING EQUIPMENT MARKET,
BY PRODUCT, 2020–2027 (USD MILLION) 211
TABLE 132 SPAIN: PRIMARY PACKAGING EQUIPMENT MARKET, BY TYPE,
2020–2027 (USD MILLION) 212
TABLE 133 SPAIN: SECONDARY PACKAGING EQUIPMENT MARKET, BY TYPE,
2020–2027 (USD MILLION) 212
TABLE 134 SPAIN: LABELING AND SERIALIZATION EQUIPMENT MARKET, BY TYPE,
2020–2027 (USD MILLION) 213
TABLE 135 SPAIN: PHARMACEUTICAL PACKAGING EQUIPMENT MARKET,
BY TYPE, 2020–2027 (USD MILLION) 213
TABLE 136 SPAIN: LIQUID PACKAGING EQUIPMENT MARKET, BY TYPE,
2020–2027 (USD MILLION) 214
TABLE 137 SPAIN: SOLID PACKAGING EQUIPMENT MARKET, BY TYPE,
2020–2027 (USD MILLION) 214
TABLE 138 SPAIN: SEMI-SOLID PACKAGING EQUIPMENT MARKET, BY TYPE,
2020–2027 (USD MILLION) 215
8.2.6 SWITZERLAND 215
8.2.6.1 Growing generics market to drive market growth 215
TABLE 139 SWITZERLAND: KEY MACROINDICATORS 216
TABLE 140 SWITZERLAND: PHARMACEUTICAL PACKAGING EQUIPMENT MARKET,
BY PRODUCT, 2020–2027 (USD MILLION) 216
TABLE 141 SWITZERLAND: PRIMARY PACKAGING EQUIPMENT MARKET, BY TYPE,
2020–2027 (USD MILLION) 217
TABLE 142 SWITZERLAND: SECONDARY PACKAGING EQUIPMENT MARKET,
BY TYPE, 2020–2027 (USD MILLION) 217
TABLE 143 SWITZERLAND: LABELING AND SERIALIZATION EQUIPMENT MARKET,
BY TYPE, 2020–2027 (USD MILLION) 218
TABLE 144 SWITZERLAND: PHARMACEUTICAL PACKAGING EQUIPMENT MARKET,
BY TYPE, 2020–2027 (USD MILLION) 218
TABLE 145 SWITZERLAND: LIQUID PACKAGING EQUIPMENT MARKET, BY TYPE,
2020–2027 (USD MILLION) 219
TABLE 146 SWITZERLAND: SOLID PACKAGING EQUIPMENT MARKET, BY TYPE,
2020–2027 (USD MILLION) 219
TABLE 147 SWITZERLAND: SEMI-SOLID PACKAGING EQUIPMENT MARKET,
BY TYPE, 2020–2027 (USD MILLION) 220
8.2.7 REST OF EUROPE 220
TABLE 148 ROE: PHARMACEUTICAL PACKAGING EQUIPMENT MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 221
TABLE 149 ROE: PRIMARY PACKAGING EQUIPMENT MARKET, BY TYPE,
2020–2027 (USD MILLION) 221
TABLE 150 ROE: SECONDARY PACKAGING EQUIPMENT MARKET, BY TYPE,
2020–2027 (USD MILLION) 222
TABLE 151 ROE: LABELING AND SERIALIZATION EQUIPMENT MARKET, BY TYPE,
2020–2027 (USD MILLION) 222
TABLE 152 ROE: PHARMACEUTICAL PACKAGING EQUIPMENT MARKET, BY TYPE,
2020–2027 (USD MILLION) 223
TABLE 153 ROE: LIQUID PACKAGING EQUIPMENT MARKET, BY TYPE,
2020–2027 (USD MILLION) 223
TABLE 154 ROE: SOLID PACKAGING EQUIPMENT MARKET, BY TYPE,
2020–2027 (USD MILLION) 224
TABLE 155 ROE: SEMI-SOLID PACKAGING EQUIPMENT MARKET, BY TYPE,
2020–2027 (USD MILLION) 224
8.3 ASIA PACIFIC 225
FIGURE 43 ASIA PACIFIC: PHARMACEUTICAL PACKAGING EQUIPMENT MARKET SNAPSHOT 226
TABLE 156 APAC: PHARMACEUTICAL PACKAGING EQUIPMENT MARKET,
BY COUNTRY, 2020–2027 (USD MILLION) 227
TABLE 157 APAC: PHARMACEUTICAL PACKAGING EQUIPMENT MARKET,
BY PRODUCT, 2020–2027 (USD MILLION) 227
TABLE 158 APAC: PRIMARY PACKAGING EQUIPMENT MARKET, BY TYPE,
2020–2027 (USD MILLION) 228
TABLE 159 APAC: SECONDARY PACKAGING EQUIPMENT MARKET, BY TYPE,
2020–2027 (USD MILLION) 228
TABLE 160 APAC: LABELING AND SERIALIZATION EQUIPMENT MARKET, BY TYPE,
2020–2027 (USD MILLION) 229
TABLE 161 APAC: PHARMACEUTICAL PACKAGING EQUIPMENT MARKET, BY TYPE,
2020–2027 (USD MILLION) 229
TABLE 162 APAC: LIQUID PACKAGING EQUIPMENT MARKET, BY TYPE,
2020–2027 (USD MILLION) 230
TABLE 163 APAC: SOLID PACKAGING EQUIPMENT MARKET, BY TYPE,
2020–2027 (USD MILLION) 230
TABLE 164 APAC: SEMI-SOLID PACKAGING EQUIPMENT MARKET, BY TYPE,
2020–2027 (USD MILLION) 231
8.3.1 CHINA 231
8.3.1.1 Favorable government initiatives to propel market growth 231
TABLE 165 CHINA: KEY MACROINDICATORS 232
TABLE 166 CHINA: PHARMACEUTICAL PACKAGING EQUIPMENT MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 232
TABLE 167 CHINA: PRIMARY PACKAGING EQUIPMENT MARKET, BY TYPE,
2020–2027 (USD MILLION) 233
TABLE 168 CHINA: SECONDARY PACKAGING EQUIPMENT MARKET, BY TYPE,
2020–2027 (USD MILLION) 233
TABLE 169 CHINA: LABELING AND SERIALIZATION EQUIPMENT MARKET, BY TYPE,
2020–2027 (USD MILLION) 234
TABLE 170 CHINA: PHARMACEUTICAL PACKAGING EQUIPMENT MARKET, BY TYPE, 2020–2027 (USD MILLION) 234
TABLE 171 CHINA: LIQUID PACKAGING EQUIPMENT MARKET, BY TYPE,
2020–2027 (USD MILLION) 235
TABLE 172 CHINA: SOLID PACKAGING EQUIPMENT MARKET, BY TYPE,
2020–2027 (USD MILLION) 235
TABLE 173 CHINA: SEMI-SOLID PACKAGING EQUIPMENT MARKET, BY TYPE,
2020–2027 (USD MILLION) 236
8.3.2 JAPAN 236
8.3.2.1 Rising geriatric population and growth in generics market to drive market growth 236
TABLE 174 JAPAN: KEY MACROINDICATORS 237
TABLE 175 JAPAN: PHARMACEUTICAL PACKAGING EQUIPMENT MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 237
TABLE 176 JAPAN: PRIMARY PACKAGING EQUIPMENT MARKET, BY TYPE,
2020–2027 (USD MILLION) 238
TABLE 177 JAPAN: SECONDARY PACKAGING EQUIPMENT MARKET, BY TYPE,
2020–2027 (USD MILLION) 238
TABLE 178 JAPAN: LABELING AND SERIALIZATION EQUIPMENT MARKET, BY TYPE,
2020–2027 (USD MILLION) 239
TABLE 179 JAPAN: PHARMACEUTICAL PACKAGING EQUIPMENT MARKET,
BY TYPE, 2020–2027 (USD MILLION) 239
TABLE 180 JAPAN: LIQUID PACKAGING EQUIPMENT MARKET, BY TYPE,
2020–2027 (USD MILLION) 240
TABLE 181 JAPAN: SOLID PACKAGING EQUIPMENT MARKET, BY TYPE,
2020–2027 (USD MILLION) 240
TABLE 182 JAPAN: SEMI-SOLID PACKAGING EQUIPMENT MARKET, BY TYPE,
2020–2027 (USD MILLION) 241
8.3.3 INDIA 241
8.3.3.1 Low manufacturing cost and skilled workforce to attract outsourcing and investments 241
TABLE 183 INDIA: KEY MACROINDICATORS 242
TABLE 184 INDIA: PHARMACEUTICAL PACKAGING EQUIPMENT MARKET,
BY PRODUCT, 2020–2027 (USD MILLION) 242
TABLE 185 INDIA: PRIMARY PACKAGING EQUIPMENT MARKET, BY TYPE,
2020–2027 (USD MILLION) 243
TABLE 186 INDIA: SECONDARY PACKAGING EQUIPMENT MARKET, BY TYPE,
2020–2027 (USD MILLION) 243
TABLE 187 INDIA: LABELING AND SERIALIZATION EQUIPMENT MARKET, BY TYPE,
2020–2027 (USD MILLION) 244
TABLE 188 INDIA: PHARMACEUTICAL PACKAGING EQUIPMENT MARKET, BY TYPE,
2020–2027 (USD MILLION) 244
TABLE 189 INDIA: LIQUID PACKAGING EQUIPMENT MARKET, BY TYPE,
2020–2027 (USD MILLION) 245
TABLE 190 INDIA: SOLID PACKAGING EQUIPMENT MARKET, BY TYPE,
2020–2027 (USD MILLION) 245
TABLE 191 INDIA: SEMI-SOLID PACKAGING EQUIPMENT MARKET, BY TYPE,
2020–2027 (USD MILLION) 246
8.3.4 SOUTH KOREA 246
8.3.4.1 Rising healthcare spending and increasing government initiatives to propel clinical trials 246
TABLE 192 COUNTRIES BUYING THE MOST KOREAN DRUGS 247
TABLE 193 SOUTH KOREA: KEY MACROINDICATORS 247
TABLE 194 SOUTH KOREA: PHARMACEUTICAL PACKAGING EQUIPMENT MARKET,
BY PRODUCT, 2020–2027 (USD MILLION) 247
TABLE 195 SOUTH KOREA: PRIMARY PACKAGING EQUIPMENT MARKET, BY TYPE,
2020–2027 (USD MILLION) 248
TABLE 196 SOUTH KOREA: SECONDARY PACKAGING EQUIPMENT MARKET,
BY TYPE, 2020–2027 (USD MILLION) 248
TABLE 197 SOUTH KOREA: LABELING AND SERIALIZATION EQUIPMENT MARKET,
BY TYPE, 2020–2027 (USD MILLION) 249
TABLE 198 SOUTH KOREA: PHARMACEUTICAL PACKAGING EQUIPMENT MARKET,
BY TYPE, 2020–2027 (USD MILLION) 249
TABLE 199 SOUTH KOREA: LIQUID PACKAGING EQUIPMENT MARKET, BY TYPE,
2020–2027 (USD MILLION) 250
TABLE 200 SOUTH KOREA: SOLID PACKAGING EQUIPMENT MARKET, BY TYPE,
2020–2027 (USD MILLION) 250
TABLE 201 SOUTH KOREA: SEMI-SOLID PACKAGING EQUIPMENT MARKET,
BY TYPE, 2020–2027 (USD MILLION) 251
8.3.5 REST OF APAC 251
TABLE 202 ROAPAC: PHARMACEUTICAL PACKAGING EQUIPMENT MARKET,
BY PRODUCT, 2020–2027 (USD MILLION) 252
TABLE 203 ROAPAC: PRIMARY PACKAGING EQUIPMENT MARKET, BY TYPE,
2020–2027 (USD MILLION) 252
TABLE 204 ROAPAC: SECONDARY PACKAGING EQUIPMENT MARKET, BY TYPE,
2020–2027 (USD MILLION) 253
TABLE 205 ROAPAC: LABELING AND SERIALIZATION EQUIPMENT MARKET,
BY TYPE, 2020–2027 (USD MILLION) 253
TABLE 206 ROAPAC: PHARMACEUTICAL PACKAGING EQUIPMENT MARKET,
BY TYPE, 2020–2027 (USD MILLION) 254
TABLE 207 ROAPAC: LIQUID PACKAGING EQUIPMENT MARKET, BY TYPE,
2020–2027 (USD MILLION) 254
TABLE 208 ROAPAC: SOLID PACKAGING EQUIPMENT MARKET, BY TYPE,
2020–2027 (USD MILLION) 255
TABLE 209 ROAPAC: SEMI-SOLID PACKAGING EQUIPMENT MARKET, BY TYPE,
2020–2027 (USD MILLION) 255

Contract Research Organization (CROs) Services Market by Type (Early phase, Clinical, Lab, Consulting), Therapeutic Area (Oncology, Infectious Disease...

Publisher:        MarketsandMarkets

# of Pages:        408

Rating: 

1 User License $4,950

Publication Date:  March, 2022

Price:       $4,950 / User License




1 INTRODUCTION 55
1.1 OBJECTIVES OF THE STUDY 55
1.2 MARKET DEFINITION 56
1.2.1 INCLUSIONS & EXCLUSIONS 56
1.3 MARKET SCOPE 57
FIGURE 1 CRO SERVICES MARKET 57
1.3.1 YEARS CONSIDERED FOR THE STUDY 58
1.4 CURRENCY 58
1.5 LIMITATIONS 58
1.6 STAKEHOLDERS 59
1.7 SUMMARY OF CHANGES 59
2 RESEARCH METHODOLOGY 61
2.1 RESEARCH DATA 61
FIGURE 2 RESEARCH DESIGN 61
2.1.1 SECONDARY DATA 62
2.1.2 PRIMARY DATA 62
FIGURE 3 CRO SERVICES MARKET: BREAKDOWN OF PRIMARIES 63
2.2 MARKET SIZE ESTIMATION 64
FIGURE 4 MARKET SIZE ESTIMATION—BOTTOM-UP (SUPPLY SIDE): COLLECTIVE REVENUE OF CRO SERVICES IN THE MARKET 64
FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS, 2021 64
FIGURE 6 AVERAGE MARKET SIZE ESTIMATION, 2021 65
2.3 GROWTH RATE ASSUMPTIONS/GROWTH FORECAST 66
FIGURE 7 CRO SERVICES MARKET: CAGR PROJECTIONS, 2022–2027 67
FIGURE 8 CRO SERVICES MARKET: GROWTH ANALYSIS OF DRIVERS, RESTRAINTS, AND OPPORTUNITIES 67
FIGURE 9 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 68
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 69
FIGURE 10 DATA TRIANGULATION METHODOLOGY 69
2.5 INSIGHTS FROM PRIMARIES 70
FIGURE 11 MARKET VALIDATION FROM PRIMARY EXPERTS 70
2.6 RESEARCH ASSUMPTIONS 70
2.6.1 COVID-19-SPECIFIC ASSUMPTIONS 71
2.7 RISK ANALYSIS 71
3 EXECUTIVE SUMMARY 72
FIGURE 12 CRO SERVICES MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION) 72
FIGURE 13 CRO SERVICES MARKET, BY THERAPEUTIC AREA,
2022 VS. 2027 (USD MILLION) 73
FIGURE 14 CRO SERVICES MARKET, BY END USER, 2022 VS. 2027 (USD MILLION) 74
FIGURE 15 GEOGRAPHICAL SNAPSHOT: CRO SERVICES MARKET 75
4 PREMIUM INSIGHTS 76
4.1 CRO SERVICES MARKET OVERVIEW 76
FIGURE 16 RISING INVESTMENTS IN PHARMACEUTICAL R&D TO DRIVE MARKET GROWTH 76
4.2 NORTH AMERICA: CRO SERVICES MARKET SHARE, BY SERVICE & COUNTRY (2021) 77
FIGURE 17 CLINICAL RESEARCH SERVICES SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICAN CRO SERVICES MARKET IN 2021 77
4.3 CRO SERVICES MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION) 78
FIGURE 18 CLINICAL RESEARCH SERVICES SEGMENT TO CONTINUE TO DOMINATE THE MARKET IN 2027 78
4.4 CRO SERVICES MARKET SHARE, BY END USER, 2021 78
FIGURE 19 PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES SEGMENT ACCOUNTED FOR THE LARGEST MARKET SHARE IN 2021 78
4.5 CRO SERVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 79
FIGURE 20 ASIA PACIFIC TO REGISTER THE HIGHEST GROWTH IN THE CRO SERVICES MARKET FROM 2022 TO 2027 79
5 MARKET OVERVIEW 80
5.1 INTRODUCTION 80
5.2 MARKET DYNAMICS 80
FIGURE 21 CRO SERVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 80
TABLE 1 CRO SERVICES MARKET: IMPACT ANALYSIS 81
5.2.1 DRIVERS 81
5.2.1.1 Increasing investment in pharmaceutical R&D 81
FIGURE 22 INCREASE IN GLOBAL PHARMACEUTICAL R&D SPENDING, 2012–2026 82
FIGURE 23 ACTIVE PHARMACEUTICAL PIPELINE, 2011–2021 83
5.2.1.2 Increasing number of clinical trial 83
FIGURE 24 NUMBER OF CLINICAL TRIALS REGISTERED WORLDWIDE (2000–2021) 83
5.2.1.3 High cost of in-house drug development 84
FIGURE 25 AVERAGE COST TO DEVELOP A PHARMACEUTICAL COMPOUND FROM DISCOVERY TO LAUNCH, 2010–2020 (USD BILLION) 84
5.2.1.4 Rising prevalence of orphan and rare diseases 85
5.2.2 OPPORTUNITIES 85
5.2.2.1 Growth in the drugs and biologics market despite the COVID-19 pandemic 85
FIGURE 26 TOTAL NUMBER OF NEW DRUGS (NEW CHEMICAL ENTITIES AND BIOLOGICS) APPROVED BY THE US FDA (2011–2021) 85
TABLE 2 LIST OF BIOLOGICS APPROVED BY THE US FDA (2021) 86
5.2.2.2 Rising demand for specialized testing services among end users 86
5.2.2.3 Need for novel clinical trial designs for complex cell and gene therapies 87
5.2.3 CHALLENGES 87
5.2.3.1 Shortage of skilled professionals for clinical trials 87
5.2.3.2 Requirement for unique analytical testing approaches for innovative formulations 88
5.2.4 MARKET TRENDS 88
5.2.4.1 Growing adoption of artificial intelligence-based tools for drug discovery 88
5.2.4.2 Increased outsourcing to emerging Asian economies 89
5.2.4.3 CRO industry consolidation 90
TABLE 3 LIST OF ACQUISITIONS 90
5.2.4.4 Integrated end-to-end R&D service solutions 91
5.3 RANGES/SCENARIOS 91
FIGURE 27 SPECTRUM OF SCENARIOS BASED ON THE IMPACT OF UNCERTAINTIES ON THE GROWTH OF THE CRO SERVICES MARKET 91
5.4 IMPACT OF COVID-19 OUTBREAK ON THE CRO SERVICES MARKET 92
FIGURE 28 CRO SERVICES MARKET SCENARIO WITH AND WITHOUT COVID-19 IMPACT, 2019–2021 92
5.5 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS 94
FIGURE 29 REVENUE SHIFT & NEW POCKETS FOR CRO SERVICE PROVIDERS 94
5.6 PRICING ANALYSIS 94
TABLE 4 AVERAGE SELLING PRICE OF CRO SERVICES, BY REGION (2020) 95
5.7 VALUE CHAIN ANALYSIS 95
FIGURE 30 VALUE CHAIN ANALYSIS OF THE CRO SERVICES MARKET: CLINICAL RESEARCH PHASES ADD MAXIMUM VALUE 96
5.8 ECOSYSTEM ANALYSIS 97
FIGURE 31 ECOSYSTEM ANALYSIS: CRO SERVICES MARKET 97
TABLE 5 SUPPLY CHAIN ECOSYSTEM 98
5.9 TECHNOLOGY ANALYSIS 99
5.10 CASE STUDIES 100
5.10.1 COVANCE FSPX DATA ANALYSIS WAS USED TO DETERMINE THE ELIGIBILITY OF PATIENTS ENROLLED FOR ONCOLOGY CLINICAL TRIALS 100
5.10.2 IQVIA PROVIDES END-TO-END CLINICAL SUPPORT TO SPONSOR 100
5.11 KEY CONFERENCES & EVENTS IN 2022–2023 100
TABLE 6 CRO SERVICES MARKET: DETAILED LIST OF CONFERENCES & EVENTS 100
5.12 REGULATORY ANALYSIS 101
5.12.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 101
TABLE 7 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 101
TABLE 8 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 102
TABLE 9 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 103
TABLE 10 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 103
5.13 PORTER’S FIVE FORCES ANALYSIS 107
TABLE 11 CRO SERVICES MARKET: PORTER’S FIVE FORCES ANALYSIS 107
5.13.1 THREAT OF NEW ENTRANTS 107
5.13.2 THREAT OF SUBSTITUTES 107
5.13.3 BARGAINING POWER OF BUYERS 108
5.13.4 BARGAINING POWER OF SUPPLIERS 108
5.13.5 DEGREE OF COMPETITION 108
5.14 KEY STAKEHOLDERS AND BUYING CRITERIA 109
5.14.1 KEY STAKEHOLDERS IN THE BUYING PROCESS 109
FIGURE 32 INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS OF CRO SERVICES 109
5.14.2 BUYING CRITERIA FOR CRO SERVICES 109
FIGURE 33 KEY BUYING CRITERIA FOR END USERS 109
6 CRO SERVICES MARKET, BY TYPE 110
6.1 INTRODUCTION 111
TABLE 12 CRO SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 111
6.2 CLINICAL RESEARCH SERVICES 111
TABLE 13 NUMBER OF REGISTERED AND RECRUITING CLINICAL STUDIES AS OF MARCH 2022, BY LOCATION 112
TABLE 14 EXAMPLES OF CLINICAL RESEARCH SERVICES OFFERED BY MARKET PLAYERS 112
FIGURE 34 DRUGS IN PIPELINE, BY DEVELOPMENT PHASE, 2020 VS. 2021 113
TABLE 15 CLINICAL RESEARCH SERVICES MARKET, BY TYPE,
2020–2027 (USD MILLION) 114
TABLE 16 CLINICAL RESEARCH SERVICES MARKET, BY REGION,
2020–2027 (USD MILLION) 114
TABLE 17 NORTH AMERICA: CLINICAL RESEARCH SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 114
TABLE 18 EUROPE: CLINICAL RESEARCH SERVICES MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 115
TABLE 19 ASIA PACIFIC: CLINICAL RESEARCH SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 115
TABLE 20 LATIN AMERICA: CLINICAL RESEARCH SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 115
6.2.1 PHASE III CLINICAL RESEARCH SERVICES 116
6.2.1.1 Rising cost of Phase III trials and high number of patients recruited in these trials to drive the demand for cost-effective CRO services 116
TABLE 21 EXAMPLES OF DRUGS THAT HAVE COMPLETED PHASE III STUDY 116
TABLE 22 PHASE III CLINICAL RESEARCH SERVICES MARKET, BY REGION,
2020–2027 (USD MILLION) 117
TABLE 23 NORTH AMERICA: PHASE III CLINICAL RESEARCH SERVICES MARKET,
BY COUNTRY, 2020–2027 (USD MILLION) 117
TABLE 24 EUROPE: PHASE III CLINICAL RESEARCH SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 117
TABLE 25 ASIA PACIFIC: PHASE III CLINICAL RESEARCH SERVICES MARKET,
BY COUNTRY, 2020–2027 (USD MILLION) 118
TABLE 26 LATIN AMERICA: PHASE III CLINICAL RESEARCH SERVICES MARKET,
BY COUNTRY, 2020–2027 (USD MILLION) 118
6.2.2 PHASE II CLINICAL RESEARCH SERVICES 118
6.2.2.1 Long duration of Phase II studies provides growth opportunities for CROs 118
TABLE 27 EXAMPLES OF DRUGS THAT HAVE COMPLETED PHASE II STUDIES 119
TABLE 28 PHASE II CLINICAL RESEARCH SERVICES MARKET, BY REGION,
2020–2027 (USD MILLION) 119
TABLE 29 NORTH AMERICA: PHASE II CLINICAL RESEARCH SERVICES MARKET,
BY COUNTRY, 2020–2027 (USD MILLION) 120
TABLE 30 EUROPE: PHASE II CLINICAL RESEARCH SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 120
TABLE 31 ASIA PACIFIC: PHASE II CLINICAL RESEARCH SERVICES MARKET,
BY COUNTRY, 2020–2027 (USD MILLION) 120
TABLE 32 LATIN AMERICA: PHASE II CLINICAL RESEARCH SERVICES MARKET,
BY COUNTRY, 2020–2027 (USD MILLION) 121
6.2.3 PHASE I CLINICAL RESEARCH SERVICES 121
6.2.3.1 Robust pipeline of pharmaceutical companies driving the growth of this market segment 121
TABLE 33 EXAMPLES OF DRUGS THAT HAVE COMPLETED PHASE I STUDIES 121
TABLE 34 PHASE I CLINICAL RESEARCH SERVICES MARKET, BY REGION,
2020–2027 (USD MILLION) 122
TABLE 35 NORTH AMERICA: PHASE I CLINICAL RESEARCH SERVICES MARKET,
BY COUNTRY, 2020–2027 (USD MILLION) 122
TABLE 36 EUROPE: PHASE I CLINICAL RESEARCH SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 123
TABLE 37 ASIA PACIFIC: PHASE I CLINICAL RESEARCH SERVICES MARKET,
BY COUNTRY, 2020–2027 (USD MILLION) 123
TABLE 38 LATIN AMERICA: PHASE I CLINICAL RESEARCH SERVICES MARKET,
BY COUNTRY, 2020–2027 (USD MILLION) 123
6.2.4 PHASE IV CLINICAL RESEARCH SERVICES 124
6.2.4.1 Increasing number of CROs are providing post-marketing surveillance 124
TABLE 39 EXAMPLES OF DRUGS THAT HAVE COMPLETED PHASE IV CLINICAL STUDIES 124
TABLE 40 PHASE IV CLINICAL RESEARCH SERVICES MARKET, BY REGION,
2020–2027 (USD MILLION) 125
TABLE 41 NORTH AMERICA: PHASE IV CLINICAL RESEARCH SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 125
TABLE 42 EUROPE: PHASE IV CLINICAL RESEARCH SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 125
TABLE 43 ASIA PACIFIC: PHASE IV CLINICAL RESEARCH SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 126
TABLE 44 LATIN AMERICA: PHASE IV CLINICAL RESEARCH SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 126
6.3 EARLY-PHASE DEVELOPMENT SERVICES 126
FIGURE 35 DRUGS IN PIPELINE, BY THERAPEUTIC AREA (2021) 127
TABLE 45 EXAMPLES OF EARLY-PHASE DEVELOPMENT SERVICES OFFERED BY MARKET PLAYERS 127
TABLE 46 EARLY-PHASE DEVELOPMENT SERVICES MARKET, BY TYPE,
2020–2027 (USD MILLION) 128
TABLE 47 EARLY-PHASE DEVELOPMENT SERVICES MARKET, BY REGION,
2020–2027 (USD MILLION) 128
TABLE 48 NORTH AMERICA: EARLY-PHASE DEVELOPMENT SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 129
TABLE 49 EUROPE: EARLY-PHASE DEVELOPMENT SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 129
TABLE 50 ASIA PACIFIC: EARLY-PHASE DEVELOPMENT SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 129
TABLE 51 LATIN AMERICA: EARLY-PHASE DEVELOPMENT SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 130
6.3.1 CHEMISTRY, MANUFACTURING AND CONTROLS SERVICES 130
6.3.1.1 CMC services are widely used to check the quality standards of drugs 130
TABLE 52 CHEMISTRY, MANUFACTURING AND CONTROLS SERVICES MARKET, BY REGION, 2020–2027 (USD MILLION) 130
TABLE 53 NORTH AMERICA: CHEMISTRY, MANUFACTURING AND CONTROLS SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 131
TABLE 54 EUROPE: CHEMISTRY, MANUFACTURING AND CONTROLS SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 131
TABLE 55 ASIA PACIFIC: CHEMISTRY, MANUFACTURING AND CONTROLS SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 131
TABLE 56 LATIN AMERICA: CHEMISTRY, MANUFACTURING AND CONTROLS SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 132
6.3.2 PRECLINICAL SERVICES 132
TABLE 57 PRECLINICAL SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 132
TABLE 58 PRECLINICAL SERVICES MARKET, BY REGION, 2020–2027 (USD MILLION) 133
TABLE 59 NORTH AMERICA: PRECLINICAL SERVICES MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 133
TABLE 60 EUROPE: PRECLINICAL SERVICES MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 133
TABLE 61 ASIA PACIFIC: PRECLINICAL SERVICES MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 134
TABLE 62 LATIN AMERICA: PRECLINICAL SERVICES MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 134
6.3.2.1 Pharmacokinetics/pharmacodynamics services 134
6.3.2.1.1 Importance of studies to determine the pharmacokinetic behavior of drug candidates is increasing 134
TABLE 63 PHARMACOKINETICS/PHARMACODYNAMICS SERVICES MARKET, BY REGION, 2020–2027 (USD MILLION) 135
TABLE 64 NORTH AMERICA: PHARMACOKINETICS/PHARMACODYNAMICS SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 135
TABLE 65 EUROPE: PHARMACOKINETICS/PHARMACODYNAMICS SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 136
TABLE 66 ASIA PACIFIC: PHARMACOKINETICS/PHARMACODYNAMICS SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 136
TABLE 67 LATIN AMERICA: PHARMACOKINETICS/PHARMACODYNAMICS SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 136
6.3.2.2 Toxicology testing services 137
6.3.2.2.1 Demand for toxicology testing is increasing to prevent late-stage failures 137
TABLE 68 TOXICOLOGY TESTING SERVICES MARKET, BY REGION,
2020–2027 (USD MILLION) 137
TABLE 69 NORTH AMERICA: TOXICOLOGY TESTING SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 138
TABLE 70 EUROPE: TOXICOLOGY TESTING SERVICES MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 138
TABLE 71 ASIA PACIFIC: TOXICOLOGY TESTING SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 138
TABLE 72 LATIN AMERICA: TOXICOLOGY TESTING SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 139
6.3.2.3 Other preclinical services 139
TABLE 73 OTHER PRECLINICAL SERVICES MARKET, BY REGION,
2020–2027 (USD MILLION) 139
TABLE 74 NORTH AMERICA: OTHER PRECLINICAL SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 140
TABLE 75 EUROPE: OTHER PRECLINICAL SERVICES MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 140
TABLE 76 ASIA PACIFIC: OTHER PRECLINICAL SERVICES MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 140
TABLE 77 LATIN AMERICA: OTHER PRECLINICAL SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 141
6.3.3 DISCOVERY STUDIES 141
6.3.3.1 Rising importance of CRO services for target identification and validation to promote segment growth 141
TABLE 78 DISCOVERY STUDIES MARKET, BY REGION, 2020–2027 (USD MILLION) 141
TABLE 79 NORTH AMERICA: DISCOVERY STUDIES MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 142
TABLE 80 EUROPE: DISCOVERY STUDIES MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 142
TABLE 81 ASIA PACIFIC: DISCOVERY STUDIES MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 142
TABLE 82 LATIN AMERICA: DISCOVERY STUDIES MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 143
6.4 LABORATORY SERVICES 143
TABLE 83 EXAMPLES OF LABORATORY SERVICES OFFERED BY PROMINENT PLAYERS 143
TABLE 84 LABORATORY SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 144
TABLE 85 LABORATORY SERVICES MARKET, BY REGION, 2020–2027 (USD MILLION) 144
TABLE 86 NORTH AMERICA: LABORATORY SERVICES MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 144
TABLE 87 EUROPE: LABORATORY SERVICES MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 145
TABLE 88 ASIA PACIFIC: LABORATORY SERVICES MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 145
TABLE 89 LATIN AMERICA: LABORATORY SERVICES MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 145
6.4.1 ANALYTICAL TESTING SERVICES 146
TABLE 90 ANALYTICAL TESTING SERVICES MARKET, BY TYPE,
2020–2027 (USD MILLION) 146
TABLE 91 ANALYTICAL TESTING SERVICES MARKET, BY REGION,
2020–2027 (USD MILLION) 146
TABLE 92 NORTH AMERICA: ANALYTICAL TESTING SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 147
TABLE 93 EUROPE: ANALYTICAL TESTING SERVICES MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 147
TABLE 94 ASIA PACIFIC: ANALYTICAL TESTING SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 147
TABLE 95 LATIN AMERICA: ANALYTICAL TESTING SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 148
6.4.1.1 Physical characterization services 148
6.4.1.1.1 Demand for physical characterization is increasing to reduce the risk of product failure 148
TABLE 96 PHYSICAL CHARACTERIZATION SERVICES MARKET, BY REGION,
2020–2027 (USD MILLION) 148
TABLE 97 NORTH AMERICA: PHYSICAL CHARACTERIZATION SERVICES MARKET,
BY COUNTRY, 2020–2027 (USD MILLION) 149
TABLE 98 EUROPE: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 149
TABLE 99 ASIA PACIFIC: PHYSICAL CHARACTERIZATION SERVICES MARKET,
BY COUNTRY, 2020–2027 (USD MILLION) 149
TABLE 100 LATIN AMERICA: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 150
6.4.1.2 Raw material testing services 150
6.4.1.2.1 Demand for raw material testing services is increasing to ensure the quality and purity of raw materials 150
TABLE 101 RAW MATERIAL TESTING SERVICES MARKET, BY REGION,
2020–2027 (USD MILLION) 150
TABLE 102 NORTH AMERICA: RAW MATERIAL TESTING SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 151
TABLE 103 EUROPE: RAW MATERIAL TESTING SERVICES MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 151
TABLE 104 ASIA PACIFIC: RAW MATERIAL TESTING SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 151
TABLE 105 LATIN AMERICA: RAW MATERIAL TESTING SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 152
6.4.1.3 Batch release testing services 152
6.4.1.3.1 Comprehensive portfolio of batch release testing services offered by CROs to propel segment growth 152
TABLE 106 BATCH RELEASE TESTING SERVICES MARKET, BY REGION,
2020–2027 (USD MILLION) 152
TABLE 107 NORTH AMERICA: BATCH RELEASE TESTING SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 153
TABLE 108 EUROPE: BATCH RELEASE TESTING SERVICES MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 153
TABLE 109 ASIA PACIFIC: BATCH RELEASE TESTING SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 153
TABLE 110 LATIN AMERICA: BATCH RELEASE TESTING SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 154
6.4.1.4 Stability testing services 154
6.4.1.4.1 Stability testing is used to ensure the long-term quality, safety, and efficacy of pharmaceutical products 154
TABLE 111 STABILITY TESTING SERVICES MARKET, BY REGION,
2020–2027 (USD MILLION) 155
TABLE 112 NORTH AMERICA: STABILITY TESTING SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 155
TABLE 113 EUROPE: STABILITY TESTING SERVICES MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 155
TABLE 114 ASIA PACIFIC: STABILITY TESTING SERVICES MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 156
TABLE 115 LATIN AMERICA: STABILITY TESTING SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 156
6.4.1.5 Other analytical testing services 156
TABLE 116 OTHER ANALYTICAL TESTING SERVICES MARKET, BY REGION,
2020–2027 (USD MILLION) 157
TABLE 117 NORTH AMERICA: OTHER ANALYTICAL TESTING SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 157
TABLE 118 EUROPE: OTHER ANALYTICAL TESTING SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 157
TABLE 119 ASIA PACIFIC: OTHER ANALYTICAL TESTING SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 158
TABLE 120 LATIN AMERICA: OTHER ANALYTICAL TESTING SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 158
6.4.2 BIOANALYTICAL TESTING SERVICES 158
6.4.2.1 Demand for bioanalytical testing has increased due to the growing use of macromolecules and biosimilars 158
TABLE 121 BIOANALYTICAL TESTING SERVICES MARKET, BY REGION,
2020–2027 (USD MILLION) 159
TABLE 122 NORTH AMERICA: BIOANALYTICAL TESTING SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 159
TABLE 123 EUROPE: BIOANALYTICAL TESTING SERVICES MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 159
TABLE 124 ASIA PACIFIC: BIOANALYTICAL TESTING SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 160
TABLE 125 LATIN AMERICA: BIOANALYTICAL TESTING SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 160
6.5 CONSULTING SERVICES 160
6.5.1 ADOPTION OF CONSULTING SERVICES IS INCREASING FOR QUALITY ASSURANCE PURPOSES 160
TABLE 126 CONSULTING SERVICES MARKET, BY REGION, 2020–2027 (USD MILLION) 161
TABLE 127 NORTH AMERICA: CONSULTING SERVICES MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 161
TABLE 128 EUROPE: CONSULTING SERVICES MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 162
TABLE 129 ASIA PACIFIC: CONSULTING SERVICES MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 162
TABLE 130 LATIN AMERICA: CONSULTING SERVICES MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 162
6.6 DATA MANAGEMENT SERVICES 163
6.6.1 DATA MANAGEMENT SERVICES EXPECTED TO RECORD THE HIGHEST CAGR DURING THE FORECAST PERIOD 163
TABLE 131 EXAMPLES OF DATA MANAGEMENT SERVICES OFFERED BY PROMINENT PLAYERS 163
TABLE 132 DATA MANAGEMENT SERVICES MARKET, BY REGION,
2020–2027 (USD MILLION) 164
TABLE 133 NORTH AMERICA: DATA MANAGEMENT SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 164
TABLE 134 EUROPE: DATA MANAGEMENT SERVICES MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 164
TABLE 135 ASIA PACIFIC: DATA MANAGEMENT SERVICES MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 165
TABLE 136 LATIN AMERICA: DATA MANAGEMENT SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 165
7 CRO SERVICES MARKET, BY THERAPEUTIC AREA 166
7.1 INTRODUCTION 167
TABLE 137 CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION) 167
7.2 ONCOLOGY 168
FIGURE 36 GLOBAL CANCER INCIDENCE, BY CANCER TYPE (2020) 168
FIGURE 37 NUMBER OF ONCOLOGY CLINICAL TRIALS STARTED GLOBALLY FROM
2011 TO 2021 (IN THOUSAND) 169
TABLE 138 LIST OF FDA DRUGS APPROVED FOR ONCOLOGY (2021) 169
TABLE 139 CRO SERVICES MARKET FOR ONCOLOGY, BY TYPE,
2020–2027 (USD MILLION) 170
TABLE 140 CRO SERVICES MARKET FOR ONCOLOGY, BY REGION,
2020–2027 (USD MILLION) 170
TABLE 141 NORTH AMERICA: CRO SERVICES MARKET FOR ONCOLOGY, BY COUNTRY, 2020–2027 (USD MILLION) 170
TABLE 142 EUROPE: CRO SERVICES MARKET FOR ONCOLOGY, BY COUNTRY,
2020–2027 (USD MILLION) 171
TABLE 143 ASIA PACIFIC: CRO SERVICES MARKET FOR ONCOLOGY, BY COUNTRY, 2020–2027 (USD MILLION) 171
TABLE 144 LATIN AMERICA: CRO SERVICES MARKET FOR ONCOLOGY, BY COUNTRY, 2020–2027 (USD MILLION) 171
7.2.1 BREAST CANCER 172
7.2.1.1 Breast cancer is the most prevalent cancer 172
TABLE 145 CRO SERVICES MARKET FOR BREAST CANCER, BY REGION,
2020–2027 (USD MILLION) 172
TABLE 146 NORTH AMERICA: CRO SERVICES MARKET FOR BREAST CANCER,
BY COUNTRY, 2020–2027 (USD MILLION) 172
TABLE 147 EUROPE: CRO SERVICES MARKET FOR BREAST CANCER, BY COUNTRY, 2020–2027 (USD MILLION) 173
TABLE 148 ASIA PACIFIC: CRO SERVICES MARKET FOR BREAST CANCER, BY COUNTRY, 2020–2027 (USD MILLION) 173
TABLE 149 LATIN AMERICA: CRO SERVICES MARKET FOR BREAST CANCER, BY COUNTRY, 2020–2027 (USD MILLION) 173
7.2.2 LUNG CANCER 174
7.2.2.1 Drug approvals indicate increasing research against lung cancer 174
TABLE 150 CRO SERVICES MARKET FOR LUNG CANCER, BY REGION,
2020–2027 (USD MILLION) 174
TABLE 151 NORTH AMERICA: CRO SERVICES MARKET FOR LUNG CANCER, BY COUNTRY, 2020–2027 (USD MILLION) 174
TABLE 152 EUROPE: CRO SERVICES MARKET FOR LUNG CANCER, BY COUNTRY,
2020–2027 (USD MILLION) 175
TABLE 153 ASIA PACIFIC: CRO SERVICES MARKET FOR LUNG CANCER, BY COUNTRY, 2020–2027 (USD MILLION) 175
TABLE 154 LATIN AMERICA: CRO SERVICES MARKET FOR LUNG CANCER, BY COUNTRY, 2020–2027 (USD MILLION) 175
7.2.3 COLORECTAL CANCER 176
7.2.3.1 Increasing number of clinical trials on treatments against colorectal cancer to drive segment growth 176
TABLE 155 CRO SERVICES MARKET FOR COLORECTAL CANCER, BY REGION,
2020–2027 (USD MILLION) 176
TABLE 156 NORTH AMERICA: CRO SERVICES MARKET FOR COLORECTAL CANCER, BY COUNTRY, 2020–2027 (USD MILLION) 176
TABLE 157 EUROPE: CRO SERVICES MARKET FOR COLORECTAL CANCER, BY COUNTRY, 2020–2027 (USD MILLION) 177
TABLE 158 ASIA PACIFIC: CRO SERVICES MARKET FOR COLORECTAL CANCER, BY COUNTRY, 2020–2027 (USD MILLION) 177
TABLE 159 LATIN AMERICA: CRO SERVICES MARKET FOR COLORECTAL CANCER, BY COUNTRY, 2020–2027 (USD MILLION) 177
7.2.4 PROSTATE CANCER 178
7.2.4.1 Increasing research initiatives on prostate cancer to drive segment growth 178
TABLE 160 CRO SERVICES MARKET FOR PROSTATE CANCER, BY REGION,
2020–2027 (USD MILLION) 178
TABLE 161 NORTH AMERICA: CRO SERVICES MARKET FOR PROSTATE CANCER, BY COUNTRY, 2020–2027 (USD MILLION) 178
TABLE 162 EUROPE: CRO SERVICES MARKET FOR PROSTATE CANCER, BY COUNTRY, 2020–2027 (USD MILLION) 179
TABLE 163 ASIA PACIFIC: CRO SERVICES MARKET FOR PROSTATE CANCER, BY COUNTRY, 2020–2027 (USD MILLION) 179
TABLE 164 LATIN AMERICA: CRO SERVICES MARKET FOR PROSTATE CANCER, BY COUNTRY, 2020–2027 (USD MILLION) 179
7.2.5 OTHER CANCERS 180
TABLE 165 CRO SERVICES MARKET FOR OTHER CANCERS, BY REGION,
2020–2027 (USD MILLION) 180
TABLE 166 NORTH AMERICA: CRO SERVICES MARKET FOR OTHER CANCERS, BY COUNTRY, 2020–2027 (USD MILLION) 180
TABLE 167 EUROPE: CRO SERVICES MARKET FOR OTHER CANCERS, BY COUNTRY, 2020–2027 (USD MILLION) 181
TABLE 168 ASIA PACIFIC: CRO SERVICES MARKET FOR OTHER CANCERS, BY COUNTRY, 2020–2027 (USD MILLION) 181
TABLE 169 LATIN AMERICA: CRO SERVICES MARKET FOR OTHER CANCERS, BY COUNTRY, 2020–2027 (USD MILLION) 181
7.3 INFECTIOUS DISEASES 182
7.3.1 EPIDEMIC OUTBREAKS ARE NECESSITATING INCREASING DRUG DISCOVERY ACTIVITIES 182
TABLE 170 CRO SERVICES MARKET FOR INFECTIOUS DISEASES, BY REGION,
2020–2027 (USD MILLION) 182
TABLE 171 NORTH AMERICA: CRO SERVICES MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2020–2027 (USD MILLION) 182
TABLE 172 EUROPE: CRO SERVICES MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2020–2027 (USD MILLION) 183
TABLE 173 ASIA PACIFIC: CRO SERVICES MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2020–2027 (USD MILLION) 183
TABLE 174 LATIN AMERICA: CRO SERVICES MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2020–2027 (USD MILLION) 183
7.4 CARDIOVASCULAR SYSTEM DISORDERS 184
7.4.1 HIGH MORTALITY RATES DRIVING PHARMACEUTICAL COMPANIES TO DEVELOP NEW TREATMENT OPTIONS 184
TABLE 175 LIST OF PIPELINE DRUGS FOR CARDIOVASCULAR DISEASES (2021) 184
TABLE 176 CRO SERVICES MARKET FOR CARDIOVASCULAR SYSTEM DISORDERS, BY REGION, 2020–2027 (USD MILLION) 185
TABLE 177 NORTH AMERICA: CRO SERVICES MARKET FOR CARDIOVASCULAR SYSTEM DISORDERS, BY COUNTRY, 2020–2027 (USD MILLION) 185
TABLE 178 EUROPE: CRO SERVICES MARKET FOR CARDIOVASCULAR SYSTEM DISORDERS, BY COUNTRY, 2020–2027 (USD MILLION) 185
TABLE 179 ASIA PACIFIC: CRO SERVICES MARKET FOR CARDIOVASCULAR SYSTEM DISORDERS, BY COUNTRY, 2020–2027 (USD MILLION) 186
TABLE 180 LATIN AMERICA: CRO SERVICES MARKET FOR CARDIOVASCULAR SYSTEM DISORDERS, BY COUNTRY, 2020–2027 (USD MILLION) 186
7.5 NEUROLOGY 186
7.5.1 INCREASING INVESTMENT IN R&D AND GRANTS FOR NEUROLOGICAL DISORDERS TO DRIVE SEGMENT GROWTH 186
TABLE 181 LIST OF PIPELINE DRUGS FOR NEUROLOGICAL DISORDERS (2021) 187
TABLE 182 CRO SERVICES MARKET FOR NEUROLOGY, BY REGION,
2020–2027 (USD MILLION) 188
TABLE 183 NORTH AMERICA: CRO SERVICES MARKET FOR NEUROLOGY, BY COUNTRY, 2020–2027 (USD MILLION) 188
TABLE 184 EUROPE: CRO SERVICES MARKET FOR NEUROLOGY, BY COUNTRY,
2020–2027 (USD MILLION) 188
TABLE 185 ASIA PACIFIC: CRO SERVICES MARKET FOR NEUROLOGY, BY COUNTRY, 2020–2027 (USD MILLION) 189
TABLE 186 LATIN AMERICA: CRO SERVICES MARKET FOR NEUROLOGY, BY COUNTRY, 2020–2027 (USD MILLION) 189
7.6 VACCINES 189
7.6.1 INCREASING INVESTMENTS IN VACCINE R&D TO DRIVE SEGMENT GROWTH 189
TABLE 187 CRO SERVICES MARKET FOR VACCINES, BY REGION,
2020–2027 (USD MILLION) 190
TABLE 188 NORTH AMERICA: CRO SERVICES MARKET FOR VACCINES, BY COUNTRY, 2020–2027 (USD MILLION) 190
TABLE 189 EUROPE: CRO SERVICES MARKET FOR VACCINES, BY COUNTRY,
2020–2027 (USD MILLION) 190
TABLE 190 ASIA PACIFIC: CRO SERVICES MARKET FOR VACCINES, BY COUNTRY,
2020–2027 (USD MILLION) 191
TABLE 191 LATIN AMERICA: CRO SERVICES MARKET FOR VACCINES, BY COUNTRY, 2020–2027 (USD MILLION) 191
7.7 METABOLIC DISORDERS/ENDOCRINOLOGY 191
7.7.1 INCREASING GLOBAL DIABETES POPULATION EXPECTED TO DRIVE SEGMENT GROWTH 191
FIGURE 38 ESTIMATED NUMBER OF INDIVIDUALS WITH DIABETES,
2000–2045 (MILLION) 192
TABLE 192 CRO SERVICES MARKET FOR METABOLIC DISORDERS/ENDOCRINOLOGY, BY REGION, 2020–2027 (USD MILLION) 192
TABLE 193 NORTH AMERICA: CRO SERVICES MARKET FOR METABOLIC DISORDERS/ENDOCRINOLOGY, BY COUNTRY, 2020–2027 (USD MILLION) 193
TABLE 194 EUROPE: CRO SERVICES MARKET FOR METABOLIC DISORDERS/ENDOCRINOLOGY, BY COUNTRY, 2020–2027 (USD MILLION) 193
TABLE 195 ASIA PACIFIC: CRO SERVICES MARKET FOR METABOLIC DISORDERS/ENDOCRINOLOGY, BY COUNTRY, 2020–2027 (USD MILLION) 193
TABLE 196 LATIN AMERICA: CRO SERVICES MARKET FOR METABOLIC DISORDERS/ENDOCRINOLOGY, BY COUNTRY, 2020–2027 (USD MILLION) 194
7.8 IMMUNOLOGICAL DISORDERS 194
7.8.1 GROWING DRUGS PIPELINE FOR IMMUNOLOGICAL DISORDERS TO DRIVE SEGMENT GROWTH 194
TABLE 197 CRO SERVICES MARKET FOR IMMUNOLOGICAL DISORDERS, BY REGION, 2020–2027 (USD MILLION) 194
TABLE 198 NORTH AMERICA: CRO SERVICES MARKET FOR IMMUNOLOGICAL DISORDERS, BY COUNTRY, 2020–2027 (USD MILLION) 195
TABLE 199 EUROPE: CRO SERVICES MARKET FOR IMMUNOLOGICAL DISORDERS, BY COUNTRY, 2020–2027 (USD MILLION) 195
TABLE 200 ASIA PACIFIC: CRO SERVICES MARKET FOR IMMUNOLOGICAL DISORDERS, BY COUNTRY, 2020–2027 (USD MILLION) 195
TABLE 201 LATIN AMERICA: CRO SERVICES MARKET FOR IMMUNOLOGICAL DISORDERS, BY COUNTRY, 2020–2027 (USD MILLION) 196
7.9 PSYCHIATRY 196
7.9.1 RISING INCIDENCE OF PSYCHIATRIC DISORDERS TO PROPEL SEGMENT GROWTH 196
TABLE 202 CRO SERVICES MARKET FOR PSYCHIATRY, BY REGION,
2020–2027 (USD MILLION) 196
TABLE 203 NORTH AMERICA: CRO SERVICES MARKET FOR PSYCHIATRY, BY COUNTRY, 2020–2027 (USD MILLION) 197
TABLE 204 EUROPE: CRO SERVICES MARKET FOR PSYCHIATRY, BY COUNTRY,
2020–2027 (USD MILLION) 197
TABLE 205 ASIA PACIFIC: CRO SERVICES MARKET FOR PSYCHIATRY, BY COUNTRY, 2020–2027 (USD MILLION) 197
TABLE 206 LATIN AMERICA: CRO SERVICES MARKET FOR PSYCHIATRY, BY COUNTRY, 2020–2027 (USD MILLION) 198
7.10 RESPIRATORY DISORDERS 198
7.10.1 INCREASING PREVALENCE OF RESPIRATORY DISORDERS TO SUPPORT SEGMENT GROWTH 198
TABLE 207 LIST OF PIPELINE DRUGS FOR RESPIRATORY DISEASES (2021) 198
TABLE 208 CRO SERVICES MARKET FOR RESPIRATORY DISORDERS, BY REGION,
2020–2027 (USD MILLION) 199
TABLE 209 NORTH AMERICA: CRO SERVICES MARKET FOR RESPIRATORY DISORDERS, BY COUNTRY, 2020–2027 (USD MILLION) 199
TABLE 210 EUROPE: CRO SERVICES MARKET FOR RESPIRATORY DISORDERS, BY COUNTRY, 2020–2027 (USD MILLION) 200
TABLE 211 ASIA PACIFIC: CRO SERVICES MARKET FOR RESPIRATORY DISORDERS, BY COUNTRY, 2020–2027 (USD MILLION) 200
TABLE 212 LATIN AMERICA: CRO SERVICES MARKET FOR RESPIRATORY DISORDERS, BY COUNTRY, 2020–2027 (USD MILLION) 200
7.11 DERMATOLOGY 201
7.11.1 INCREASING PREVALENCE OF SKIN DISORDERS TO PROPEL SEGMENT GROWTH 201
TABLE 213 LIST OF PIPELINE DRUGS FOR SKIN DISEASES (2021) 201
TABLE 214 CRO SERVICES MARKET FOR DERMATOLOGY, BY REGION,
2020–2027 (USD MILLION) 202
TABLE 215 NORTH AMERICA: CRO SERVICES MARKET FOR DERMATOLOGY, BY COUNTRY, 2020–2027 (USD MILLION) 202
TABLE 216 EUROPE: CRO SERVICES MARKET FOR DERMATOLOGY, BY COUNTRY,
2020–2027 (USD MILLION) 202
TABLE 217 ASIA PACIFIC: CRO SERVICES MARKET FOR DERMATOLOGY, BY COUNTRY, 2020–2027 (USD MILLION) 203
TABLE 218 LATIN AMERICA: CRO SERVICES MARKET FOR DERMATOLOGY, BY COUNTRY, 2020–2027 (USD MILLION) 203
7.12 OPHTHALMOLOGY 203
7.12.1 GROWING NEED FOR OPHTHALMOLOGY-RELATED CLINICAL TRIALS TO DRIVE SEGMENT GROWTH 203
TABLE 219 CRO SERVICES MARKET FOR OPHTHALMOLOGY, BY REGION,
2020–2027 (USD MILLION) 204
TABLE 220 NORTH AMERICA: CRO SERVICES MARKET FOR OPHTHALMOLOGY, BY COUNTRY, 2020–2027 (USD MILLION) 204
TABLE 221 EUROPE: CRO SERVICES MARKET FOR OPHTHALMOLOGY, BY COUNTRY, 2020–2027 (USD MILLION) 204
TABLE 222 ASIA PACIFIC: CRO SERVICES MARKET FOR OPHTHALMOLOGY, BY COUNTRY, 2020–2027 (USD MILLION) 205
TABLE 223 LATIN AMERICA: CRO SERVICES MARKET FOR OPHTHALMOLOGY, BY COUNTRY, 2020–2027 (USD MILLION) 205
7.13 GASTROINTESTINAL DISEASES 205
7.13.1 RISING INCIDENCE OF GASTROINTESTINAL DISEASES TO PROPEL SEGMENT GROWTH 205
TABLE 224 CRO SERVICES MARKET FOR GASTROINTESTINAL DISEASES, BY REGION, 2020–2027 (USD MILLION) 206
TABLE 225 NORTH AMERICA: CRO SERVICES MARKET FOR GASTROINTESTINAL DISEASES, BY COUNTRY, 2020–2027 (USD MILLION) 206
TABLE 226 EUROPE: CRO SERVICES MARKET FOR GASTROINTESTINAL DISEASES, BY COUNTRY, 2020–2027 (USD MILLION) 206
TABLE 227 ASIA PACIFIC: CRO SERVICES MARKET FOR GASTROINTESTINAL DISEASES, BY COUNTRY, 2020–2027 (USD MILLION) 207
TABLE 228 LATIN AMERICA: CRO SERVICES MARKET FOR GASTROINTESTINAL DISEASES, BY COUNTRY, 2020–2027 (USD MILLION) 207